Although 2009 is certainly a year to forget - Unquote
Although 2009 is certainly a year to forget - Unquote
Although 2009 is certainly a year to forget - Unquote
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
unquote<br />
France<br />
LA RÉFÉRENCE PAR EXCELLENCE DU PRIVATE EQUITY EN FRANCE<br />
Issue 114 AUGUST/SEPTEMBER 2010<br />
Early-stage and expansion deals: less <strong>is</strong> more<br />
FOLLOWING SUBDUED DEAL activity in May, France saw a strong<br />
increase in early-stage and expansion transactions in June. In the last<br />
few weeks, unquote” has covered 16 such deals, doubling May’s <strong>to</strong>tal.<br />
However, the French market <strong>is</strong> still lagging behind last <strong>year</strong>’s level of<br />
activity in terms of volume.<br />
<strong>Although</strong> <strong>2009</strong> <strong>is</strong> <strong>certainly</strong> a <strong>year</strong> <strong>to</strong><br />
<strong>forget</strong> for most private equity professionals,<br />
Volume<br />
France saw more early-stage and expansion<br />
Value<br />
20<br />
investments in the first half of <strong>2009</strong> than<br />
over the same period in 2010: 81 such 15<br />
transactions were recorded by unquote” in<br />
<strong>2009</strong>, against 63 th<strong>is</strong> <strong>year</strong>.<br />
10<br />
Despite th<strong>is</strong> relative slowdown, the<br />
5<br />
overall value of deals has seen a slight but<br />
noticeable increase in 2010. Early-stage<br />
0<br />
January February March<br />
and expansion transactions in the first six<br />
months of <strong>2009</strong> amounted <strong>to</strong> 477m,<br />
Volume<br />
SINCE THE BEGINNING of the <strong>year</strong>,<br />
France has been the most dynamic market for<br />
investments in the internet sec<strong>to</strong>r, along with<br />
Germany. Activity picked up again th<strong>is</strong> month,<br />
echoing the surge witnessed last March.<br />
Crédit Agricole Private Equity and A Plus<br />
Finance provided 4m for e-commerce<br />
solutions provider Oxat<strong>is</strong>, which helps<br />
French SMEs <strong>to</strong> set up their own merchant<br />
sites (see page 20). Meanwhile, BNP Paribas<br />
Private Equity invested a further 1.8m in<br />
internet communications special<strong>is</strong>t Acropol<strong>is</strong><br />
while the aggregated value th<strong>is</strong> <strong>year</strong> stands at 506m. The average deal<br />
value in France therefore has increased from 5.89m in the first half of<br />
<strong>2009</strong> <strong>to</strong> 8.04m in 2010, indicating larger investment rounds. Th<strong>is</strong> has<br />
largely been driven by the renewed interest in the life sciences sec<strong>to</strong>r,<br />
which usually requires bigger financing<br />
rounds. The number of investments<br />
in pharmaceutical and biotechnology<br />
companies has gone up from four in <strong>2009</strong><br />
150<br />
120<br />
90<br />
<strong>to</strong> six in 2010. But more significantly, their<br />
value has increased almost five-fold, from<br />
12m <strong>to</strong> 57m.<br />
The first weeks of July seem <strong>to</strong> confirm<br />
60<br />
30<br />
the sec<strong>to</strong>r’s vitality: France witnessed its<br />
largest series-A round of financing in almost<br />
five <strong>year</strong>s, with the 16m investment in<br />
0<br />
April May June<br />
Poxel – another biotechnology company<br />
Source: unquote”/Private Equity Insight (see page 17).<br />
Early-stage and expansion deals in France - H1 2010<br />
French internet sec<strong>to</strong>r continues <strong>to</strong> flour<strong>is</strong>h<br />
Value (m)<br />
Telecom (see page 21).<br />
On the exit side, private equity inves<strong>to</strong>rs<br />
have sold their stakes in France’s biggest e-<br />
commerce success-s<strong>to</strong>ry, with the 200m sale<br />
of PriceMin<strong>is</strong>ter <strong>to</strong> Japanese group Rakuten<br />
(see page 28).<br />
Have you v<strong>is</strong>ited the new France homepage yet?<br />
www.unquote.com/france<br />
Can’t log in? Don’t know your username or password?<br />
Contact Nicola Tillin on +44 207 484 9884 or nicola.tillin@inc<strong>is</strong>ivemedia.com<br />
Quick view<br />
Funds 04<br />
News in brief 05<br />
People 06<br />
Corporate M&A 08<br />
Tertiary buyouts 09<br />
Life sciences 10<br />
ILPA 11<br />
Watch 12<br />
European round-up 14<br />
Deal sec<strong>to</strong>r index 16<br />
Exits 28<br />
Funds ra<strong>is</strong>ing 32<br />
Funds investing 34<br />
IPO tracker 40<br />
Diary dates 42<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 01<br />
www.unquote.com/france
In <br />
uncertain times, there are still some<br />
investments <br />
that will pay dividends. IE<br />
Consulting <br />
can help you understand<br />
how <br />
current and future developments<br />
will <br />
impact your reputation and your<br />
ability <br />
<strong>to</strong> do business. And we can<br />
tell <br />
you how your competition will be<br />
affected, <br />
<strong>to</strong>o. We can also help you ra<strong>is</strong>e<br />
capital, <br />
source and execute deals and<br />
safeguard <br />
and create value.<br />
<br />
<br />
<br />
<br />
<br />
<br />
supporting <br />
private equity
unquote<br />
contents<br />
04<br />
08<br />
News<br />
Funds 04<br />
News in brief 05<br />
People 06<br />
Analys<strong>is</strong><br />
Corporate M&A 08<br />
Tertiary buyouts 09<br />
Life sciences 10<br />
ILPA 11<br />
Watch 12<br />
European round-up 14<br />
Deals<br />
Deal sec<strong>to</strong>r index 16<br />
Early-stage 17<br />
Poxel 17<br />
McPhy Energy 17<br />
EyeTechCare 18<br />
Expansion 19<br />
Groupe Chr<strong>is</strong>tian Bernard 19<br />
Redman Promotion 19<br />
Oxat<strong>is</strong> 20<br />
Nuxeo 20<br />
Acropol<strong>is</strong> Telecom 21<br />
Novapost 22<br />
Devederm 22<br />
Comu<strong>to</strong> (Covoiturage.fr) 23<br />
FInteractive 24<br />
Intégral Système 24<br />
Kall<strong>is</strong>ta Energy 25<br />
Buyouts 26<br />
Thermocoax 26<br />
Hyper Embal/Valeurd<strong>is</strong> 27<br />
Groupe ACR 27<br />
Exits<br />
PriceMin<strong>is</strong>ter 28<br />
Carmat SAS 29<br />
Groupe Keria 30<br />
Trecobat 30<br />
Funds ra<strong>is</strong>ing 32<br />
Funds investing 34<br />
IPO tracker 40<br />
Diary dates 42<br />
16<br />
28<br />
We aim <strong>to</strong> validate fully all<br />
investment, divestment and fundra<strong>is</strong>ing<br />
data via direct contact with the<br />
investment professionals themselves.<br />
Th<strong>is</strong> policy, combined with the scale of<br />
our edi<strong>to</strong>rial and research operation,<br />
enables Inc<strong>is</strong>ive Financial Publ<strong>is</strong>hing<br />
journals <strong>to</strong> offer the prov<strong>is</strong>ion of broad,<br />
detailed and accurate data.<br />
Follow us on Twitter for<br />
breaking French private<br />
equity news:<br />
twitter.com/Franceunquote<br />
ISSN – 1467-0062<br />
Volume 2010/8<br />
Annual Subscription (Standard Plus):<br />
£1,500/2,250/$2,700<br />
Publ<strong>is</strong>hed by<br />
Inc<strong>is</strong>ive Financial Publ<strong>is</strong>hing ltd<br />
Haymarket House<br />
28-29 Haymarket<br />
London<br />
SW1Y 4RX<br />
UK<br />
Tel: +44 20 7484 9700<br />
Fax: +44 20 7004 7548<br />
All rights reserved. No part of th<strong>is</strong> publication<br />
may be reproduced or s<strong>to</strong>red in a database or<br />
electronic retrieval system, transmitted in any<br />
form or by any means, electronic, mechanical,<br />
pho<strong>to</strong>copied, recorded or otherw<strong>is</strong>e, without<br />
prior written perm<strong>is</strong>sion from the publ<strong>is</strong>hers. No<br />
statement in th<strong>is</strong> journal <strong>is</strong> <strong>to</strong> be construed as a<br />
recommendation <strong>to</strong> buy or sell securities.<br />
Acting Edi<strong>to</strong>r-in-Chief &<br />
Head of Research<br />
Emanuel Eftimiu<br />
emanuel.eftimiu@inc<strong>is</strong>ivemedia.com<br />
Edi<strong>to</strong>r-in-Chief<br />
Kimberly Romaine<br />
kimberly.romaine@inc<strong>is</strong>ivemedia.com<br />
Reporters<br />
Gregoire Gille – gregoire.gille@inc<strong>is</strong>ivemedia.com<br />
Vik<strong>to</strong>r Lundvall – vik<strong>to</strong>r.lundvall@inc<strong>is</strong>ivemedia.com<br />
Gail Mwamba – gail.mwamba@inc<strong>is</strong>ivemedia.com<br />
Online Edi<strong>to</strong>r<br />
John Bakie<br />
john.bakie@inc<strong>is</strong>ivemedia.com<br />
Publ<strong>is</strong>hing Direc<strong>to</strong>r<br />
Catherine Lew<strong>is</strong><br />
catherine.lew<strong>is</strong>@inc<strong>is</strong>ivemedia.com<br />
Advert<strong>is</strong>ing & Sponsorship Manager<br />
Stephen O’Sullivan<br />
stephen.osullivan@inc<strong>is</strong>ivemedia.com<br />
Production Edi<strong>to</strong>r<br />
Tim Kimber<br />
tim.kimber@inc<strong>is</strong>ivemedia.com<br />
Sub-edi<strong>to</strong>r<br />
Eleanor Stanley<br />
eleanor.stanley@inc<strong>is</strong>ivemedia.com<br />
Marketing<br />
Helen Longhurst<br />
helen.longhurst@inc<strong>is</strong>ivemedia.com<br />
Subscription Sales<br />
Nicola Tillin<br />
nicola.tillin@inc<strong>is</strong>ivemedia.com<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 03<br />
www.unquote.com/france
funds<br />
Name<br />
Gilde Buyout Fund IV<br />
Closed on<br />
800m (June 2010)<br />
Focus<br />
Buyouts, mid-market, Europe<br />
Contact<br />
Koos Teule<br />
Gilde Buy Out Partners BV<br />
New<strong>to</strong>nlaan 91<br />
PO Box 85067<br />
3508 AB Utrecht<br />
Netherlands<br />
Tel : +31 30 219 2508<br />
Adv<strong>is</strong>ers<br />
MV<strong>is</strong>ion (Placement agent); SJ<br />
Berwin (Legal)<br />
unquote<br />
Gilde’s latest fund reaches 800m hard-cap<br />
Fund<br />
Gilde Buyout Partners has closed its Gilde Buyout Fund IV on 800m. Launched in March <strong>2009</strong>,<br />
the vehicle has a 10-<strong>year</strong> lifespan, with the potential <strong>to</strong> extend by two one-<strong>year</strong> periods. Based in the<br />
Netherlands, the fund was oversubscribed and reached its hard-cap following strong inves<strong>to</strong>r interest.<br />
Management fees have been set at 1.65%, while the hurdle and carry follow the industry standard of<br />
8% and 20% respectively. Carried interest will be paid on the fund as a whole. MV<strong>is</strong>ion acted as global<br />
placing agent and SJ Berwin was mandated as legal adv<strong>is</strong>er. Gilde’s previous buyout fund, Gilde Buyout<br />
Fund III, reached its 600m target in September 2006. To date, it has completed nine investments.<br />
Inves<strong>to</strong>rs<br />
The fund has attracted 45 contribu<strong>to</strong>rs, with several previous Gilde inves<strong>to</strong>rs returning. 50% of<br />
commitments came from Europe, 35% from the US and 15% from the Asia Pacific. Pension plans and<br />
sovereign wealth funds account for the majority of the inves<strong>to</strong>r base.<br />
Investments<br />
Gilde aims <strong>to</strong> make equity investments of 25-200m in mid-market companies across a wide range of<br />
industries, with a core focus on the Benelux, German-speaking and French economies. The fund expects<br />
<strong>to</strong> perform around 15 investments over its lifetime, several of which are said <strong>to</strong> be already in the pipeline.<br />
People<br />
The fund <strong>is</strong> managed by the Gilde buyout team, led by Boudewijn Molenaar.<br />
Name<br />
Argos Expansion<br />
Closed on<br />
45m (July 2010)<br />
Target<br />
120m<br />
Focus<br />
Expansion, SMEs, France<br />
Contact<br />
Constance Jay<br />
Argos Soditic<br />
14, rue de Bassano<br />
75783 Par<strong>is</strong> Cedex 16<br />
France<br />
Tel: +33 1 53 67 20 50<br />
Adv<strong>is</strong>ers<br />
Proskauer Rose (Legal)<br />
Latest Argos fund holds 45m first close<br />
Fund<br />
Argos Soditic has closed its Argos Expansion fund on 45m. The vehicle will make its first investments while<br />
continuing <strong>to</strong> ra<strong>is</strong>e funds from LPs, with a final target of 120m. The fund has a 10-<strong>year</strong> lifespan with a five<strong>year</strong><br />
investment period. Officially launched in January 2008, it started receiving commitments in <strong>2009</strong>.<br />
Based in France, Argos Expansion <strong>is</strong> an FCPR benefiting from simplified author<strong>is</strong>ation procedures.<br />
Management fees have been set at 2%, hurdle at 7% and carry at 20%. While no placing agent was<br />
mandated, Proskauer Rose acts as legal adv<strong>is</strong>er <strong>to</strong> the fund.<br />
Inves<strong>to</strong>rs<br />
Argos Expansion has received commitments from 14 inves<strong>to</strong>rs so far. The EIF and CDC Entrepr<strong>is</strong>es,<br />
acting on behalf of the French Strategic Investment Fund (FSI), have contributed along with the three<br />
fund managers. The vehicle <strong>is</strong> looking <strong>to</strong> attract commitments from France and the rest of Europe.<br />
Investments<br />
The fund will provide development and acqu<strong>is</strong>ition financing for small and medium-sized French<br />
enterpr<strong>is</strong>es (SMEs) already held or being acquired by their management teams. It will typically invest<br />
between 2-12m in junior capital (sponsorless mezzanine) and minority equity. The fund should<br />
perform between 10-15 investments in businesses with enterpr<strong>is</strong>e values ranging from 10-100m.<br />
People<br />
An independent management team cons<strong>is</strong>ting of three partners – Olivier Bossan, Lou<strong>is</strong> de Lestanville<br />
and Jean de Sampigny – will manage the fund’s operations and investments.<br />
04 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
Carlyle set <strong>to</strong> exit O<strong>to</strong>r<br />
CARLYLE HAS entered in<strong>to</strong> exclusive d<strong>is</strong>cussions with<br />
packaging and office supplies wholesaler DS Smith, regarding<br />
the acqu<strong>is</strong>ition of Carlyle’s stake in l<strong>is</strong>ted company O<strong>to</strong>r.<br />
The transaction would involve the sale of 94.75% of O<strong>to</strong>r’s share<br />
capital, which Carlyle acquired in 2005. In addition, shares<br />
retained by O<strong>to</strong>r’s chairman would also be sold <strong>to</strong> DS Smith,<br />
which would then control more than 95% of the company.<br />
DS Smith has offered 8.97 per O<strong>to</strong>r share, which would value<br />
the company at 247m, including a 47m debt. Following<br />
completion of the transaction by the end of 2010, DS Smith<br />
intends <strong>to</strong> launch an offer for the remaining l<strong>is</strong>ted shares. O<strong>to</strong>r <strong>is</strong> a<br />
French corrugated cardboard packaging manufacturer, operating<br />
six box plants, three specialty sheet plants, two paper mills and<br />
one packaging machine unit. Floated on NYSE Alternext Par<strong>is</strong> in<br />
1998, it posted revenues of 315m in <strong>2009</strong>.<br />
news in brief<br />
Avenir et al. back Société<br />
Hôtelière Côte Rôtie<br />
AVENIR ENTREPRISES, Sofival, BNP Paribas<br />
Développement, Garibaldi Participations and R<strong>is</strong>que &<br />
Sérénité have funded the buyout of eight hotels on behalf of<br />
Société Hôtelière Côte Rôtie (SHCR).<br />
The eight hotels, located in the Rhône-Alpes region of France,<br />
were acquired from Groupe Accor for an und<strong>is</strong>closed amount.<br />
Sofival, a local real estate developer, contributed 39% of the<br />
funds. The remainder was provided by private equity houses<br />
Avenir Entrepr<strong>is</strong>es (21%), BNP Paribas Développement (17%),<br />
Garibaldi Participations (7%) and R<strong>is</strong>que & Sérénité (5%).<br />
SHCR was created <strong>to</strong> operate hotels and aims <strong>to</strong> take<br />
advantage of the region’s <strong>to</strong>ur<strong>is</strong>t potential, especially for<br />
skiing holidays.<br />
AIFM vote put back <strong>to</strong> autumn<br />
A CRUCIAL VOTE on the AIFM<br />
Directive has been delayed until<br />
September.<br />
Issues regarding third country rules,<br />
which would limit the capabilities of<br />
non-EU domiciled hedge, private<br />
equity and venture capital funds, led<br />
<strong>to</strong> the collapse of talks between the<br />
European parliament and country<br />
representatives.<br />
The European comm<strong>is</strong>sion had set<br />
an ambitious target of agreeing the<br />
regulations by the end of th<strong>is</strong> month.<br />
However, the Span<strong>is</strong>h EU presidency<br />
says it will not be possible <strong>to</strong> reach an<br />
agreement in June, and the vote has<br />
now been delayed until the second<br />
parliamentary session in September<br />
th<strong>is</strong> <strong>year</strong>.<br />
A delay in holding the vote gives<br />
lobby<strong>is</strong>ts crucial extra time <strong>to</strong> push<br />
for changes in the draft leg<strong>is</strong>lation,<br />
which could negatively impact private<br />
equity and venture capital investment<br />
in Europe.<br />
Seventure leads Nutrionix investment<br />
PREVIOUS INVESTORS Seventure Partners have worked with seven business<br />
angels <strong>to</strong> provided additional funding for French-based Nutrionix, a company that<br />
special<strong>is</strong>es in the reduction of sodium in food.<br />
The first round of funding from Seventure of 900,000 completed in spring<br />
<strong>2009</strong> enabled Nutrionix <strong>to</strong> launch its first commercial product, K-Salt, and<br />
accelerate product development. Th<strong>is</strong> second round of funding was arranged<br />
<strong>to</strong> take advantage of increasingly receptive market conditions and the need <strong>to</strong><br />
accelerate development.<br />
Lloyds sells UK<br />
portfolio <strong>to</strong><br />
Coller Capital<br />
LLOYDS BANKING GROUP has<br />
become the latest bank <strong>to</strong> cut its private<br />
equity exposure, selling its £480m<br />
portfolio of UK private equity stakes <strong>to</strong><br />
a newly created joint venture, Cavend<strong>is</strong>h<br />
Square Partners.<br />
Lloyds will jointly own the venture with<br />
Coller Capital, which has agreed <strong>to</strong> pay<br />
£332m for 70% of the venture, while the<br />
bank maintains a 30% stake.<br />
The deal will see a transfer of 40 UK<br />
trading companies <strong>to</strong> the new vehicle,<br />
currently managed by Bank of Scotland<br />
Integrated Finance (BOSIF). Coller<br />
won the deal through an auction<br />
process, with the agreement subject <strong>to</strong><br />
regula<strong>to</strong>ry approval.<br />
Lloyds expects <strong>to</strong> complete the transfer<br />
of the assets and ex<strong>is</strong>ting BOSIF<br />
management team <strong>to</strong> the new vehicle by<br />
the third quarter of 2010.<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 05<br />
www.unquote.com/france
news in brief<br />
LBO France plans<br />
Medi-Partenaires exit<br />
LBO FRANCE <strong>is</strong> working on plans <strong>to</strong> exit its stake in French<br />
healthcare provider Medi-Partenaires SA, according <strong>to</strong> media<br />
reports. Rothschild has reportedly been hired <strong>to</strong> handle the<br />
sale, which <strong>is</strong> estimated <strong>to</strong> be valued at about 1bn.<br />
LBO France led the 600m secondary buyout of the company<br />
in 2007, investing alongside Barclays Private Equity, Crédit<br />
Agricole and Intermediate Capital.<br />
unquote<br />
AlpInvest sale rumoured<br />
THE OWNERS OF private equity heavyweight AlpInvest could<br />
be looking for a sale, according <strong>to</strong> reports. AlpInvest <strong>is</strong> owned<br />
by Dutch pension funds ABP and PGGM. ABP, AlpInvest and<br />
Crédit Su<strong>is</strong>se, which <strong>is</strong> rumoured <strong>to</strong> have been mandated for<br />
the sale, have all declined <strong>to</strong> comment.<br />
Founded in 1999, AlpInvest <strong>is</strong> one of the largest European<br />
private equity firms. With more than 40bn under management,<br />
it special<strong>is</strong>es in fund investments, secondary investments, coinvestments<br />
and mezzanine transactions.<br />
AXA Private Equity buys Phönix/Strack Group<br />
AXA PRIVATE EQUITY has acquired<br />
a majority stake in Phönix/Strack<br />
Group, a special valves supplier <strong>to</strong> the<br />
chemicals industry.<br />
No financial details for the transaction have<br />
been d<strong>is</strong>closed, but the inves<strong>to</strong>r <strong>is</strong> looking<br />
<strong>to</strong> grow the company internationally<br />
through add-on acqu<strong>is</strong>itions, as well as by<br />
exploiting ex<strong>is</strong>ting market opportunities.<br />
Founded in 1910, Phönix/Strack<br />
manufactures special valves for<br />
international blue-chip companies in<br />
the fields of energy, petrochemicals and<br />
chemicals. The group generated revenues<br />
of approximately 40m in <strong>2009</strong> and<br />
employs a workforce of 250 at its plants<br />
in Volkmarsen and Magdeburg, as well<br />
as through its sales entities in France and<br />
the US.<br />
people moves<br />
Edmond de<br />
Rothschild CP<br />
strengthens team<br />
Edmond de Rothschild Capital Partners<br />
has recruited a new investment direc<strong>to</strong>r<br />
and analyst. It has also promoted one of<br />
its analysts <strong>to</strong> asset manager.<br />
Aymeric Marraud des Grottes has been<br />
appointed as investment direc<strong>to</strong>r. He<br />
previously worked as an analyst and later<br />
associate for JP Morgan, which he joined<br />
in 2001.<br />
Marie Londero <strong>is</strong> joining the firm as an<br />
analyst, having recently graduated from<br />
the ESCP-EAP school.<br />
BNP Paribas Private Equity<br />
appoints Rivet-Fusil as FoF head<br />
BNP Paribas Private Equity has appointed Jean-Marc Rivet-Fusil <strong>to</strong> head its fundsof-funds<br />
team. He has been charged with defining and implementing the firm’s<br />
fund-of-funds strategy, which includes defining and supporting the d<strong>is</strong>tribution<br />
of tailored offerings.<br />
Rivet-Fusil will form part of the two-person investment committee, working alongside<br />
Stéphanie Egoian, who has been promoted <strong>to</strong> chief investment officer. Egoian will be<br />
in charge of coordinating the fund’s investment strategy <strong>to</strong> define its funds selection<br />
and investment processes.<br />
Rivet-Fusil joined BNP Paribas in 2007 as chief investment officer, coming<br />
from Amundi. He has also held previous roles at Access Capital Partners, Banexi<br />
Ventures Partners and Banexi Participations, covering funds selection, venture<br />
capital, buyouts and mezzanine financing. Egoian joined as investment direc<strong>to</strong>r<br />
in 1999 and has also worked as chief financial officer of the company’s Europe<br />
Telecom & Media Fund.<br />
06 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
EUROPEAN<br />
FUNDRAISING<br />
REVIEW 2010<br />
LOOKING TO RAISE FUNDS IN<br />
EUROPE IN 2010 AND BEYOND?<br />
The ninth edition of the European Fundra<strong>is</strong>ing Review <strong>is</strong> out now.<br />
Th<strong>is</strong> essential guide provides you with an in-depth analys<strong>is</strong> of<br />
private equity and venture capital fundra<strong>is</strong>ing activity for each major<br />
European region.<br />
Order your copy now by calling+44 (0)20 7968 4506<br />
and quoting ref: FPA<br />
In association with:<br />
unquote.com
corporate M&A<br />
unquote<br />
Corporates trump private equity<br />
in European M&A<br />
Private equity continues <strong>to</strong> lag behind corporate buyers in size of merger and<br />
acqu<strong>is</strong>ition (M&A) deals executed in Europe, as cash-rich corporate players flex<br />
their muscles <strong>to</strong> offer both capital and synergies in the space.<br />
Gail Mwamba reports<br />
The first half of th<strong>is</strong> <strong>year</strong> has seen a significant pick-up in<br />
M&A activity, with deal-making in Europe estimated <strong>to</strong> have<br />
reached about $230bn in the first half of 2010. A significant<br />
number of these deals have been executed by corporates<br />
making acqu<strong>is</strong>itions, which includes the purchase of Cogn<strong>is</strong><br />
by BASF for an estimated enterpr<strong>is</strong>e value of 3.1bn.<br />
According <strong>to</strong> Edward<br />
Boyce, Nomura’s Londonbased<br />
managing direc<strong>to</strong>r of<br />
investment banking, the <strong>to</strong>p<br />
20 largest deals seen in Europe,<br />
the Middle East and Africa<br />
(EMEA) th<strong>is</strong> <strong>year</strong> have been<br />
executed by corporates.<br />
“The <strong>to</strong>p deals we have seen<br />
th<strong>is</strong> <strong>year</strong> in EMEA, in terms<br />
of size, have been corporates<br />
buying corporates,” says Boyce.<br />
“They are situations where a trade buyer <strong>is</strong> a better solution,<br />
and a private equity inves<strong>to</strong>r cannot compete because it <strong>is</strong><br />
not able <strong>to</strong> provide the same synergies.”<br />
According <strong>to</strong> Boyce, corporate players are able <strong>to</strong> sometimes<br />
win over vendors because they generally offer a longer<br />
holding period, while private equity inves<strong>to</strong>rs tend <strong>to</strong> seek<br />
<strong>to</strong> exit within three <strong>to</strong> five <strong>year</strong>s.<br />
Corporates are also able <strong>to</strong> reign in situations where the target<br />
company will require constant streams of cash <strong>to</strong> survive,<br />
which may be a d<strong>is</strong>advantage for private equity players who<br />
are generally geared <strong>to</strong> finance acqu<strong>is</strong>itions. In recent times,<br />
corporates have increasingly been able <strong>to</strong> provide th<strong>is</strong> kind<br />
of support, as many are sitting on large pots of money, some<br />
of which has been gained through retained earnings.<br />
“Securing funding <strong>is</strong> not<br />
an <strong>is</strong>sue for us, as we have<br />
cashflows that have been<br />
generated organically,”<br />
says Swag Mukerji, chief<br />
financial officer at Londonbased<br />
washing machine<br />
producer SafetyKleen.<br />
“Fortunately, we have been<br />
resilient <strong>to</strong> the recession.”<br />
However, the availability<br />
for corporates of sustained<br />
cashflow and the potential for synergies with their targets has<br />
not been enough <strong>to</strong> purchase significant assets from private<br />
equity players.<br />
According <strong>to</strong> unquote” data, although exiting via trade sales<br />
constituted about 44% of deal volume in the first half of 2010,<br />
th<strong>is</strong> only amounted <strong>to</strong> 17% of <strong>to</strong>tal value. Th<strong>is</strong> <strong>is</strong> compared<br />
<strong>to</strong> secondary buyouts, where 28% of volume equated <strong>to</strong> 44%<br />
in deal value. It remains <strong>to</strong> be seen if corporates will extend<br />
their reign <strong>to</strong> th<strong>is</strong> space as well. <br />
08 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
tertiary buyouts<br />
Tertiary buyouts:<br />
passing it on<br />
As deal-making fever returns <strong>to</strong> the market, tertiary sales appear <strong>to</strong> be<br />
back in vogue for a number of private equity inves<strong>to</strong>rs looking <strong>to</strong> put<br />
their secondary assets on the block. Gail Mwamba reports<br />
French pharmaceutical firm Cerba European Lab was recently<br />
sold by IK Investment Partners <strong>to</strong> PAI partners in an estimated<br />
500m tertiary buyout. PAI backed the 2006 secondary buyout<br />
from As<strong>to</strong>rg Partners. However, the company’s private equity<br />
investment h<strong>is</strong><strong>to</strong>ry stretches back even further, having been backed<br />
by Initiative & Finance and Natex<strong>is</strong> in a previous funding round.<br />
Barclays Private Equity also chose <strong>to</strong> go with a private equity<br />
player in its sale of UK luggage brand Antler in May, <strong>to</strong> Lloyds<br />
Development Capital – the third time the firm had been backed<br />
by a private equity inves<strong>to</strong>r. BPE bought the company from<br />
Royal Bank Equity Finance in 2004, with the vendor having<br />
backed its first buyout in 1999.<br />
Some tertiary deals have been spurred by inves<strong>to</strong>rs looking for<br />
more experienced buyers able <strong>to</strong> offer speed of execution as well<br />
as an attractive deal price. Th<strong>is</strong> was the case for Change Capital<br />
Partners, which th<strong>is</strong> month sold UK fashion retailer Republic in<br />
a tertiary deal <strong>to</strong> TPG Capital for an estimated £300m. Change<br />
Capital backed the company in a 2005 SBO from 3i.<br />
“There was a lot of private equity and trade interest in the<br />
business, and we made the dec<strong>is</strong>ion <strong>to</strong> pursue the option of<br />
a financial buyer based on both price and timing,” says Steve<br />
Petrow, managing direc<strong>to</strong>r at Change Capital Partner in<br />
London. “Trade players had a lot of interest, but the time frame<br />
that we were working within was quite difficult.”<br />
However, for Herkules, which recently sold Nordic healthcare<br />
equipment manufacturer Handicare <strong>to</strong> Nordic Capital, financial<br />
backers were specifically sought as Handicare was in need of<br />
fresh capital. Herkules, which had bought the company from<br />
AAC Capital Partners in 2005, ran out of capital in its first fund<br />
and was not able <strong>to</strong> finance further growth.<br />
“We invited only financial parties, and we had strong interest<br />
from Nordic and European funds, as well as US funds with<br />
offices in Europe,” says Patrik Egeland, partner at Herkules in<br />
Oslo. “We felt the company would benefit from having more<br />
capital <strong>to</strong> grow.”<br />
According <strong>to</strong> Petrow, the industry <strong>is</strong> expecting <strong>to</strong> see more<br />
tertiary deals in the future. Th<strong>is</strong> may well be the case, with recent<br />
reports of private equity buyers reportedly having joined the race<br />
<strong>to</strong> buy Bain Capital’s Italian software company, TeamSystem<br />
SpA, for an estimated 600m. Bain bought the company in a<br />
secondary buyout from Palamon Capital Partners in 2004.<br />
The spurt in tertiary activity may reflect difficult conditions<br />
in other exit markets, as the world economy remains weak.<br />
However, with some sellers specifically targeting other private<br />
equity buyers, believing they can bring something more <strong>to</strong> the<br />
business, it could indicate inves<strong>to</strong>rs are adopting a longer-term<br />
view, hoping their portfolio companies will continue <strong>to</strong> thrive<br />
long after inves<strong>to</strong>r and company part ways. <br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 09<br />
www.unquote.com/france
life sciences<br />
unquote<br />
Life sciences:<br />
testing times ahead?<br />
Pharmaceuticals and biotechnology have fared marginally better than other sec<strong>to</strong>rs<br />
during the global recession, but the last two <strong>year</strong>s have still been lacklustre for<br />
private equity investments in life sciences. However, with a healthy number of deals<br />
already th<strong>is</strong> <strong>year</strong>, what <strong>is</strong> on the cards for the rest of 2010? Greg Gille reports<br />
As in many sec<strong>to</strong>rs, the <strong>to</strong>p end of the life sciences market<br />
struggled the most in both 2008 and <strong>2009</strong>. Buyouts more than<br />
halved; unquote” only recorded four each <strong>year</strong>, down from a 10<br />
per <strong>year</strong> average between 2005 and 2007. Expansion deals were<br />
also scarce, with 16 in 2008 and 18 in <strong>2009</strong>, compared <strong>to</strong> an<br />
average 35 per <strong>year</strong> recorded between 2005 and 2007.<br />
However, early-stage investments remained in line with<br />
pre-2007 levels. <strong>2009</strong> saw 54 venture capital investments, a<br />
marginal improvement on the<br />
46 per <strong>year</strong> average recorded<br />
between 2004 and 2006.<br />
Venture capital<strong>is</strong>ts remained<br />
active throughout the cr<strong>is</strong><strong>is</strong>,<br />
betting strategic investments<br />
in innovative businesses would<br />
prove fruitful in the coming<br />
<strong>year</strong>s. Michiel de Haan,<br />
partner at venture firm Aescap,<br />
explains: “We are interested<br />
in companies that are very<br />
ambitious and we therefore aim<br />
for the long term. If you want<br />
<strong>to</strong> be a successful venture firm in life sciences, you cannot look<br />
for exits on the short term.”<br />
So far th<strong>is</strong> <strong>year</strong>, there have been five buyouts in the sec<strong>to</strong>r,<br />
already <strong>to</strong>pping both 2008 and <strong>2009</strong>. The <strong>year</strong> started with<br />
a bang from Charterhouse Capital, which bought Deb Group<br />
from Barclays for a generous £325m. Other notable deals<br />
include AAC Capital’s £100m acqu<strong>is</strong>ition of Martindale<br />
Pharmaceuticals, as well as the £400m Cerba Lab buyout by<br />
PAI partners.<br />
As far as venture investments are concerned, the 27 earlystage<br />
and 14 expansion deals recorded in the first half of 2010<br />
point <strong>to</strong> a return <strong>to</strong> pre-cr<strong>is</strong><strong>is</strong> levels of activity, in both volume<br />
and value. De Haan highlights the strengths of Europe for the<br />
near future: “Life sciences has a very favourable outlook, with<br />
an ageing population and a growing need for better medicine<br />
and healthcare; emerging countries also offer opportunities<br />
for European life sciences firms. Technology has always been<br />
better in Europe than in the US; what has been lacking for the<br />
last 20 <strong>year</strong>s and now reversed<br />
<strong>is</strong> the human capital.”<br />
That <strong>is</strong>, of course, if inves<strong>to</strong>rs<br />
stay on track, for a looming<br />
hurdle might test their resolve<br />
<strong>to</strong> support innovation through<br />
the economic slowdown. The<br />
AIFM Directive <strong>is</strong> <strong>certainly</strong> a<br />
cause for concern for venture<br />
firms; portfolio d<strong>is</strong>closure in<br />
particular <strong>is</strong> seen as a major<br />
competitive d<strong>is</strong>advantage for<br />
innovative companies, left open<br />
<strong>to</strong> the prying eyes of competi<strong>to</strong>rs.<br />
The EVCA <strong>is</strong> vocally opposing the directive and warns that<br />
many firms could s<strong>to</strong>p investing al<strong>to</strong>gether. “Small startups<br />
are hit the hardest by regulation, which <strong>is</strong> aimed at big<br />
banks and large private equity houses. It <strong>is</strong> alarming how<br />
governments urge us <strong>to</strong> promote innovation, but make it very<br />
difficult for investment companies,” de Haan adds. However,<br />
he leaves the door open <strong>to</strong> optim<strong>is</strong>m: “It hurts, but obviously<br />
we have <strong>to</strong> get over it.” <br />
10 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
ILPA<br />
Broad-brush solution<br />
<strong>to</strong> a complex <strong>is</strong>sue?<br />
In a buyer’s market it <strong>is</strong> hardly surpr<strong>is</strong>ing that there has been a real focus on realigning<br />
various terms & conditions of private equity funds <strong>to</strong> favour LP inves<strong>to</strong>rs.<br />
But are attempts <strong>to</strong> drive and perhaps formal<strong>is</strong>e th<strong>is</strong> process wide of the mark?<br />
Julian Longhurst investigates<br />
It’s a sign of the times: the inves<strong>to</strong>r relations partner of a well<br />
respected European mid-cap inves<strong>to</strong>r <strong>is</strong> nervous of h<strong>is</strong> group’s<br />
upcoming fundra<strong>is</strong>ing programme. Despite having multiple<br />
previous funds under its belt and an innate confidence in the firm’s<br />
tried and tested investment strategy, the current conditions make<br />
it hard <strong>to</strong> predict how the fundra<strong>is</strong>ing process will pan out.<br />
Of course, while there may have been a short window of<br />
fundra<strong>is</strong>ing activity in the first four or five months of the <strong>year</strong>,<br />
macroeconomic demons have<br />
once again made the situation<br />
worse for any GPs doing the<br />
fundra<strong>is</strong>ing rounds. But there are<br />
other <strong>is</strong>sues making the process<br />
more onerous: the significantly<br />
more thorough LP due diligence<br />
process <strong>is</strong> one thing, along with<br />
a strong push from the buy-side<br />
<strong>to</strong> secure more LP-friendly terms<br />
and conditions.<br />
In th<strong>is</strong> regard, LPs have had some<br />
help from the Institutional Limited<br />
Partner Association (ILPA), a US organ<strong>is</strong>ation with some 220<br />
members in 10 countries. ILPA has built a set of principles aimed<br />
at serving as “a bas<strong>is</strong> for continued d<strong>is</strong>cussion between the general<br />
partner and limited partner”. The principles have <strong>certainly</strong> lent<br />
some weight <strong>to</strong> LPs’ calls for changes in areas such as management<br />
fees, transaction fees, GP fund contributions, key-man and nofault<br />
clauses, and transparency, especially in carry d<strong>is</strong>tribution.<br />
While the general shift in power has <strong>certainly</strong> precipitated some<br />
notable concessions in Ts&Cs (note Apollo and Blacks<strong>to</strong>ne as<br />
cases in point), there are those that suggest the principles are a<br />
knee jerk reaction <strong>to</strong> <strong>is</strong>sues endemic at the <strong>to</strong>p end of the scale and<br />
represent <strong>to</strong>o simpl<strong>is</strong>tic a solution for the industry as a whole.<br />
A good example of th<strong>is</strong>, according <strong>to</strong> one mid-market special<strong>is</strong>t,<br />
<strong>is</strong> the practice of GPs taking a large slice of the transaction fees<br />
they earn, rather than passing it all <strong>to</strong> the fund: “Larger funds<br />
will never get away with th<strong>is</strong> again – it <strong>is</strong> such a conflict of<br />
interests. But, the <strong>is</strong>sue <strong>is</strong> nowhere near as clear for much smaller<br />
funds, whose operational<br />
costs are d<strong>is</strong>proportionately<br />
high in compar<strong>is</strong>on <strong>to</strong> their<br />
management fee income.<br />
For them, the ability <strong>to</strong><br />
supplement income via<br />
transaction fees can be<br />
important in some cases.”<br />
It <strong>is</strong> not just GPs who think it<br />
so, and research suggests only<br />
one in eight LPs will ins<strong>is</strong>t on<br />
the full implementation of the<br />
principles, suggesting that the<br />
“one size fits all” approach really doesn’t work.<br />
Whatever the rights or wrongs of ILPA’s principles, between<br />
now and the end of 2012 virtually every private equity group<br />
that currently invests from an external fund will have gone out<br />
<strong>to</strong> market <strong>to</strong> ra<strong>is</strong>e new money, so we could be some way from<br />
knowing exactly how far the pendulum will swing <strong>to</strong>wards LPs. <br />
A more detailed look at the fundra<strong>is</strong>ing environment will be covered<br />
in the August/September <strong>is</strong>sue of Private Equity Europe.<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 11<br />
www.unquote.com/france
France watch period <strong>to</strong> end June 2010<br />
unquote<br />
PERIOD TO END<br />
JUNE 2010<br />
Figures are based on all expansion/early-stage transactions in France that were confirmed as having an<br />
institutional private equity or mezzanine inves<strong>to</strong>r as a lead or syndicate partner.<br />
For further information on Inc<strong>is</strong>ive Media’s data and research please call Emanuel Eftimiu on:<br />
+44 20 7004 7464.<br />
Volume<br />
15<br />
12<br />
9<br />
6<br />
3<br />
YTD 2010 Volume 13<br />
YTD 2010 Value<br />
€89.7m<br />
0<br />
0<br />
Q2 2005 Q4 2005 Q2 2006 Q4 2006 Q2 2007 Q4 2007 Q2 2008 Q4 2008 Q2 <strong>2009</strong> Q4 <strong>2009</strong> Q2 2010<br />
Q2 2005<br />
Q4 2005<br />
Q2 2006<br />
Q4 2006<br />
Q2 2007<br />
Q4 2007<br />
Q2 2008<br />
Q4 2008<br />
Source: unquote”<br />
Number and <strong>to</strong>tal value in m of French early-stage deals per quarter.<br />
Q2 <strong>2009</strong><br />
Q4 <strong>2009</strong><br />
Early-stage<br />
Q2 2010<br />
100<br />
80<br />
60<br />
40<br />
20<br />
Value (€m)<br />
Volume<br />
40<br />
35<br />
30<br />
25<br />
20<br />
15<br />
10<br />
5<br />
YTD 2010 Volume 48<br />
YTD 2010 Value<br />
388.2m<br />
0<br />
0<br />
Q2 2005 Q4 2005 Q2 2006 Q4 2006 Q2 2007 Q4 2007 Q2 2008 Q4 2008 Q2 <strong>2009</strong> Q4 <strong>2009</strong> Q2 2010<br />
Q2 2005<br />
Q4 2005<br />
Q2 2006<br />
Q4 2006<br />
Q2 2007<br />
Q4 2007<br />
Q2 2008<br />
Q4 2008<br />
Q2 <strong>2009</strong><br />
Q4 <strong>2009</strong><br />
Expansion<br />
Q2 2010<br />
Source: unquote”<br />
Number and <strong>to</strong>tal value in m of French expansion deals per quarter.<br />
* Does not include PIPE deals like Cinven’s 1.518bn investment in Eutelsat in Q4 2004, nor any<br />
refinancings like the SigmaKalon 1.6bn deal in Q3 2005<br />
500<br />
400<br />
300<br />
200<br />
100<br />
Value (m)<br />
Figures are based on all buyouts in France with a recorded or estimated value of 10m+ that were confirmed as having an<br />
institutional private equity or mezzanine inves<strong>to</strong>r as a lead or syndicate partner.<br />
Volume<br />
YTD 2010 Volume 15<br />
YTD 2010 Value 3.1bn<br />
60<br />
15<br />
50<br />
12<br />
40<br />
9<br />
30<br />
6<br />
20<br />
10<br />
3<br />
0<br />
0<br />
Q2 2005 Q4 2005 Q2 2006 Q4 2006 Q2 2007 Q4 2007 Q2 2008 Q4 2008 Q2 <strong>2009</strong> Q4 <strong>2009</strong> Q2 2010<br />
Q2 2005<br />
Q4 2005<br />
Q2 2006<br />
Q4 2006<br />
Q2 2007<br />
Q4 2007<br />
Q2 2008<br />
Q4 2008<br />
Q2 <strong>2009</strong><br />
Q4 <strong>2009</strong><br />
Q2 2010<br />
Buyouts<br />
Value (bn)<br />
Volume<br />
European buyouts<br />
YTD 2010 Volume 121<br />
YTD 2010 Value 19bn<br />
250<br />
80<br />
70<br />
200<br />
60<br />
150<br />
50<br />
40<br />
100<br />
30<br />
20<br />
50<br />
10<br />
0<br />
0<br />
Q2 2005 Q4 2005 Q2 2006 Q4 2006 Q2 2007 Q4 2007 Q2 2008 Q4 2008 Q2 <strong>2009</strong> Q4 <strong>2009</strong> Q2 2010<br />
Q2 2005<br />
Q4 2005<br />
Q2 2006<br />
Q4 2006<br />
Q2 2007<br />
Q4 2007<br />
Q2 2008<br />
Q4 2008<br />
Q2 <strong>2009</strong><br />
Q4 <strong>2009</strong><br />
Q2 2010<br />
Value (bn)<br />
Source: unquote”<br />
Number and <strong>to</strong>tal value of 10m+ French buyouts per quarter.<br />
Source: unquote”<br />
Number and <strong>to</strong>tal value of European 10m+ buyouts per quarter<br />
12 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
Financial<br />
3/25/09 5:53:18 PM<br />
<br />
<br />
<br />
<br />
fxweek.com<br />
countries”.<br />
<br />
<br />
<br />
Sales head quits BarCap 2<br />
Athanasopoulos resigns<br />
FX bonuses down 60% 3<br />
Napier Sco t releases latest<br />
remuneration report<br />
Rabobank reshuffle 4<br />
Changes in structured products<br />
Cognotec tackles liquidity 6<br />
New liquidity management<br />
module launched<br />
Saxo Bank results 9<br />
Forex b osts income<br />
StreamBase 6.3 a rives 11<br />
Improved FX o fering from new<br />
CEP software<br />
<br />
<br />
<br />
May 2 09<br />
start of April.<br />
WWW.FINANCIALDIRECTOR.CO.UK<br />
declaration said.<br />
9<br />
8<br />
3/4/09 18:51:03<br />
Struggling <strong>to</strong><br />
keep up with<br />
the news?<br />
Look no further.<br />
With over 100 magazines, newsletters, journals and websites covering every<br />
Inc<strong>is</strong>ive Media provides you with the<br />
intelligence <strong>to</strong>olkit you need <strong>to</strong> succeed in <strong>to</strong>day’s changing markets.<br />
Inc<strong>is</strong>ive Media creates tailor-made packages <strong>to</strong> give you the edge.<br />
Call our information team and find out how a bespoke package will make your business work smarter<br />
LONDON<br />
Nicky on +44 (0)20 7968 4569<br />
or email him at<br />
nicky.hudson@inc<strong>is</strong>ivemedia.com<br />
watersonline.com<br />
APRIL <strong>2009</strong><br />
APRIL <strong>2009</strong> BUY VS. BUILD | FIX FOR FX | EXCEL RISK | ALGO TRADING | WATERS DEBATE<br />
Drastic<br />
Cutbacks<br />
Severely slashed IT budgets and headcounts<br />
force a shift in the buy-vs.-build argument.<br />
WATERS DEBATE<br />
Hire American?<br />
FIX for FX<br />
Tackling Excel R<strong>is</strong>k<br />
Technology<br />
Inte ligence<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
FX Week<br />
The global business o foreign exchange April 6 <strong>2009</strong> v.20 n.14<br />
G-20 plans global systemic r<strong>is</strong>k regime<br />
<br />
<br />
LONDON – A declaration by the Group of of the financial sec<strong>to</strong>r. They wi l also submi<br />
<strong>to</strong> regula<strong>to</strong>ry peer reviews. No details large hedge funds, which wi l be required<br />
impact on systemic r<strong>is</strong>k. Th<strong>is</strong> includes<br />
20 leading economies (G-20) fleshed out<br />
plans for a global regime of systemic r<strong>is</strong>k have emerged on when the FSB wi l be <strong>to</strong> reg<strong>is</strong>ter and supply information <strong>to</strong><br />
regulation, “covering regulated banks, establ<strong>is</strong>hed, what its exact responsibilities national regula<strong>to</strong>rs on questions such as<br />
shadow banks and private pools of capital<br />
the amount of leverage they employ. Any<br />
<strong>to</strong> limit the build-up of systemic r<strong>is</strong>k”.<br />
counterparties <strong>to</strong> trades with hedge funds<br />
A communiqué i sued after the group’s<br />
wi l be required <strong>to</strong> have e fective r<strong>is</strong>k management,<br />
se ting limits for single counter-<br />
London summit on April 2 said the plans<br />
would establ<strong>is</strong>h “much greater cons<strong>is</strong>tency<br />
and systemi co-operation betw en<br />
moni<strong>to</strong>r the leverage of the funds.<br />
party exposures and using mechan<strong>is</strong>ms <strong>to</strong><br />
To prevent regula<strong>to</strong>ry arbitrage, the FSB<br />
At the centre of the proposals lay plans<br />
wi l draw up guidelines <strong>to</strong> help national<br />
<strong>to</strong> increase the role of the Financial Stability<br />
Forum, which would be given<br />
stitutes a systemica ly-important financial<br />
authorities determine exactly what con-<br />
greater powers and renamed the Financial<br />
institution, market or instrument. “These<br />
Stability Board (FSB). Participating are and who it senior sta f wi l be. guidelines should focus on what institutions<br />
do rather than their legal form,” the<br />
countries – compr<strong>is</strong>ing the FSB’s cu rent Participating countries agr ed <strong>to</strong> amend<br />
members, plus Spain – wi l commit <strong>to</strong> thei regula<strong>to</strong>ry systems <strong>to</strong> encompass a l<br />
maintaining financial stability, and regulated banks, shadow banks and private<br />
pools of capital that might have an for co-operation between<br />
The FSB wi l also develop mechan<strong>is</strong>ms<br />
enhancing the openne s and transparency<br />
national<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
SEOUL – The International rates su fered significant<br />
Swaps and Derivatives A sociation<br />
(Isda) has a tacked tri lion won ($1.2 bi lion),<br />
losses, estimated <strong>to</strong> reach 1.7<br />
South Korean court rulings prompting them <strong>to</strong> sue the<br />
on FX ba rier options, for banks <strong>to</strong> have the contracts<br />
undermining the contractual cance led, also a cusing them<br />
commitments of the over-thecounter<br />
derivatives market. won has dropped 24% since<br />
of unfairness and fraud. The<br />
The cases involve FX knockin/knock-out<br />
(Kiko) options against the US do lar at the<br />
September 15 <strong>to</strong> reach 1,379<br />
contracts that Korean inves<strong>to</strong>rs<br />
bought between 2007 Dec<strong>is</strong>ions have been made in<br />
cus<strong>to</strong>mers <strong>to</strong> s<strong>to</strong>p-lo s.<br />
and last <strong>year</strong>, <strong>to</strong> protect them 11 cases, including four cases<br />
against won appreciation, where the Seoul Central D<strong>is</strong>trict<br />
Court ruled in favour of<br />
with many opting for the<br />
cheaper ba rier options. However,<br />
when the US do lar made a preliminary injunction due<br />
the companies, granting them<br />
a turnaround last <strong>year</strong>, corpo-<br />
<strong>to</strong> “changed circumstances”. the favourable dec<strong>is</strong>ion.<br />
In reviewing the cases, the<br />
courts considered whether the<br />
banks had fu ly d<strong>is</strong>closed the<br />
r<strong>is</strong>ks <strong>to</strong> cus<strong>to</strong>mers, the suitability<br />
of the products, the<br />
magnitude of losses incurred<br />
– relative <strong>to</strong> the financial<br />
strength of the company – and<br />
whether the banks had performed<br />
their duties <strong>to</strong> adv<strong>is</strong>e<br />
Citibank and Woori Bank<br />
have won the cases brought<br />
against them over advice <strong>to</strong><br />
clients about s<strong>to</strong>p lo ses, but<br />
Isda last Wednesday (April 1)<br />
attacked the reasoning behind<br />
NEW YORK<br />
Ceci on +1 212 457 7860 or email<br />
ceci.recalde@inc<strong>is</strong>ivemedia.com<br />
Inside<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
The G-20 countries agreed<br />
<strong>to</strong> amend thei regula<strong>to</strong>ry<br />
systems <strong>to</strong> encompass a l<br />
regulated banks, shadow<br />
banks and private pools of<br />
capital that might have an<br />
impact on systemic r<strong>is</strong>k<br />
<br />
Isda pans Korean courts over options rulings<br />
CCE S: FTSE-1 0 FDs AND THEIR INSTITUTES GR EN SHOOTS? OR PUSHING UP DAISIES? STOCK PRICES UP, RETAIL PRICES DOWN THANK YOU, DARLING<br />
FINANCIALDIRECTOR<br />
CREATIVE ACCOUNTANTS<br />
HOW TO SEE THE PICTURE<br />
BEHIND THE NUMBERS<br />
HONG KONG<br />
Roopam +852 3411 4837 or email<br />
Roopam@inc<strong>is</strong>ivemedia.com<br />
inc<strong>is</strong>ivemedia.com<br />
inc<strong>is</strong>ive-events.com
European round-up<br />
unquote<br />
Benelux unquote”<br />
June may have been rather sedate, but the Benelux region could soon witness its biggest deal in <strong>year</strong>s. TPG and Goldman Sachs’<br />
private equity wing are closing in on a 1.2bn deal <strong>to</strong> buy Belgian nappy maker Ontex from Candover. The bid originally<br />
stumbled when Goldman Sachs’ initial partner withdrew from the sale. However, TPG’s involvement put it back on track and the<br />
sale should be completed in the coming weeks.<br />
News was otherw<strong>is</strong>e scarce on the buyout front; Apax Partners agreed <strong>to</strong> acquire BNP Paribas’s Belgian personal finance arm for<br />
an und<strong>is</strong>closed amount. Meanwhile, Barclays Private Equity bought MPS Meat Processing Systems in a secondary buyout from<br />
Steadfast Capital.<br />
In the Netherlands, Gilde Buyout Partners closed its Gilde Buyout Fund IV on 800m. Launched in March <strong>2009</strong>, the vehicle<br />
will make equity investments of 25-200m in mid-market companies across a wide range of industries, with a core focus on the<br />
Benelux, German-speaking and French economies.<br />
Last but not least, all eyes could turn <strong>to</strong> Amsterdam if reports of an AlpInvest sale were <strong>to</strong> material<strong>is</strong>e. Owned by Dutch pension<br />
funds ABP and PGGM, AlpInvest <strong>is</strong> one of the largest European private equity firms. With more than 40bn under management,<br />
it special<strong>is</strong>es in fund investments, secondary investments, co-investments and mezzanine transactions.<br />
Deutsche unquote”<br />
The DACH region has seen a steady increase in activity across the board. Fundra<strong>is</strong>ing has seen its first recorded activity in a<br />
few months with Sw<strong>is</strong>s-based SAM Private Equity holding a first close on its cleantech fund-of-funds. Buyout activity has been<br />
reasonably prevalent, with a number of deals being closed in the last few weeks. HgCapital’s acqu<strong>is</strong>ition of Teufel Speakers from<br />
Riverside <strong>is</strong> a recent significant transaction.<br />
Another secondary buyout, Nordic Capital’s acqu<strong>is</strong>ition of German company SiC Processing, was one of the more prominent<br />
investments for the region. The value of the deal was not d<strong>is</strong>closed, but the acqu<strong>is</strong>ition gave exiting inves<strong>to</strong>r Frog Capital a 3x<br />
return on investment. Other deals of note include NORD Holding’s MBO of Uhlig Rohrbogen GmbH and Chequers Capital’s<br />
66m acqu<strong>is</strong>ition of Versatel Kabel.<br />
Early-stage and expansion deals in the DACH region have been highly active, with Earlybird accounting for three investments,<br />
in CrowdPark, B2X Care Solutions and ubitricity. Additionally, WHEB Ventures provided 4.4m in expansion funding for<br />
VIA Optronics.<br />
The exit window, which seems <strong>to</strong> have opened lately, has seen a few more deals close. Apart from the two exits included in the<br />
secondary buyouts already mentioned, Permira, Goldman Sachs Capital Partners and SV Life Sciences exited Cogn<strong>is</strong> in a trade<br />
sale <strong>to</strong> BASF. The exit gave a reported 3x return on investment for Permira.<br />
Nordic unquote”<br />
The Nordic market has once again proven <strong>to</strong> be a strong source for private equity activity. The number of deals has continuously<br />
grown in the first half of the <strong>year</strong>, as the Nordic region prepares for the summer holidays. There have been two fund closures in<br />
the last few weeks, with CapMan Buyout IX and the secondaries fund Cubera V reaching final close. Both funds will focus on the<br />
Nordic region.<br />
Chalmers Innovation led the increase in early-stage and expansion investments recorded by unquote”. A <strong>to</strong>tal of five investments<br />
have been reported by the inves<strong>to</strong>r in recent month. Other early-stage deals include Vækstfonden’s investment in biotech company<br />
En<strong>to</strong>moPharm and Norinnova’s backing of VIV<strong>is</strong>ion Roller. The largest expansion deal was for NOK 52m in resort opera<strong>to</strong>r<br />
14 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
European round-up<br />
Målselv Utvikling. Other deals of note included two investments by Fouriertransform and Almi’s backing of Videofy.me.<br />
Buyout activity in the Nordic region has seen a large increase over the last few weeks. A <strong>to</strong>tal of eight buyouts were recorded,<br />
including Tri<strong>to</strong>n’s SEK 1.3bn MCS acqu<strong>is</strong>ition and Ra<strong>to</strong>s’ DKK 1.09bn S<strong>to</strong>fa buyout. CapMan’s acqu<strong>is</strong>ition of INR and Aspen<br />
was another high profile buyout.<br />
Exits have also seen an increase, with five having been recorded. One IPO has taken place, with CapMan’s partial exit of MQ.<br />
However, with the cancellation of EPiServer’s IPO, things haven’t been entirely rosy for the IPO market. It will be interesting <strong>to</strong><br />
see if the increasing activity will be maintained after summer.<br />
Southern Europe unquote”<br />
The number of deal completions in the Southern European buyout segment remains subdued, but there are signs that the debt<br />
market <strong>is</strong> open for business: although not yet a done deal, reports early in July suggested that the multi-billion-euro package<br />
of debt needed <strong>to</strong> support CVC’s buyout bid for Span<strong>is</strong>h infrastructure business Albert<strong>is</strong> had been approved. If the deal goes<br />
through it will value Albert<strong>is</strong> at around 25bn. Only two other buyouts – both smaller mid-cap acqu<strong>is</strong>itions – are known <strong>to</strong> have<br />
been completed since early June.<br />
In further bad news for buyout inves<strong>to</strong>rs in the region, the large banking syndicate holding debt in Span<strong>is</strong>h bakery business<br />
Panrico reached an agreement over a debt-for-equity swap, which sees backer Apax Partners losing the majority of its holding in<br />
the business.<br />
Outside of the buyout area, dealflow has also been scarce with just a handful of expansion and early-stage transactions being<br />
confirmed across the region. The most significant transaction came in the form of Ambienta’s 30m expansion capital investment<br />
in the Italian industrial cooling systems producer Spig SpA.<br />
Despite the gloomy deal conditions there <strong>is</strong> clearly some cause for optim<strong>is</strong>m as Madrid-based law firm Gómez-Acebo & Pombo<br />
recently announced its intention <strong>to</strong> create a new stand-alone private equity practice. The new group will provide a multid<strong>is</strong>ciplinary<br />
offering, encompassing M&A, tax, f<strong>is</strong>cal, fund structuring and regula<strong>to</strong>ry advice.<br />
UK & Ireland unquote”<br />
<strong>Although</strong> activity in the UK continued <strong>to</strong> be concentrated around the lower- <strong>to</strong> mid-market region, the market saw at least one<br />
deal exceed the £250m mark. The largest of the 14 deals in the buyout segment was TPG Capital’s £300m purchase of UK<br />
fashion retailer Republic from Change Capital Partners. Th<strong>is</strong> marked the third time the company had been backed by a private<br />
equity group, as inves<strong>to</strong>rs continue <strong>to</strong> view the fashion segment with high-growth expectations.<br />
Indeed fashion and entertainment seemed <strong>to</strong> be the flavour of the month, with Gala Coral finally completing its restructuring, as<br />
Apollo Management, Cerberus, Park Square and York Capital Management <strong>to</strong>ok over as equity inves<strong>to</strong>rs – replacing Candover,<br />
Cinven and Permira. The previous inves<strong>to</strong>rs are estimated <strong>to</strong> have lost about £670m on their original investment in the gaming<br />
company, after the mezzanine inves<strong>to</strong>rs swapped £558m of debt for equity, and injected £200m in new cash.<br />
The entertainment sec<strong>to</strong>r also saw CVC take a 28% stake in Merlin, boosting the expansion segment, which saw about 12 deals.<br />
Fashion was also en vogue in expansion, with Balder<strong>to</strong>n Capital investing $9m in UK online fashion retailer my-wardrobe.com;<br />
Advent Venture Partners investing $4.5m in online fashion company farfetch.com; and Key Capital Partners backing UK fashion<br />
company Fly53 with a £1m investment.<br />
Venture deal-making remained relatively subdued, seeing only two deals. The larger of the two was Finance Wales’s investment<br />
in software and computer services company, Altech Software. The company received funding <strong>to</strong> market its newly developed food<br />
processing software.<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 15<br />
www.unquote.com/france
deal sec<strong>to</strong>r index<br />
unquote<br />
DEALS<br />
VALUE<br />
(M)<br />
TYPE NAME LEAD BACKERS REGION PAGE<br />
AUTO PARTS n/d MBO Groupe ACR EQUITY: Nextstage<br />
DEBT: LCL, SocGen<br />
Gennevilliers 27<br />
BIOTECHNOLOGY 16m Early-stage Poxel EQUITY: EdRIP Lyon 17<br />
BUILDING<br />
MATERIALS AND<br />
FIXTURES<br />
CLOTHING<br />
ACCESSORIES<br />
CONTAINERS AND<br />
PACKAGING<br />
FINANCIAL<br />
ADMINISTRATION<br />
INDUSTRIAL<br />
SUPPLIERS<br />
unquote<br />
early-stage<br />
Early-stage transactions include start-up/seed and early-stage equity investments. Start-up/seed financing <strong>is</strong> provided <strong>to</strong> companies for use<br />
in product development and initial marketing. Companies may be in the process of being set up or may have been in business for a short<br />
time, but have not sold their product commercially. Early-stage financing allows companies which have completed the product development<br />
stage and require further funds <strong>to</strong> initiate commercial manufacturing and sales. They may not yet be generating any revenues.<br />
EdRIP et al. invest 16m in Poxel<br />
Transaction<br />
Edmond de Rothschild Investment Partners (EdRIP), CDC Entrepr<strong>is</strong>es and Crédit Agricole Private<br />
Equity have provided drugs developer Poxel with a 16m series-A round of financing.<br />
EdRIP contributed 8m <strong>to</strong> the round via its Biod<strong>is</strong>covery 3 FCPR, Partenariat & Innovation 2 FCPI<br />
and Partenariat & Innovation 3 FCPI funds. CDC invested 5m via the InnoBio fund, a vehicle it <strong>is</strong><br />
managing on behalf of the state-backed Fonds Stratégique d’Invest<strong>is</strong>sement.<br />
EARLY-STAGE<br />
Poxel<br />
16m<br />
Location Lyon<br />
Sec<strong>to</strong>r Biotechnology<br />
Founded <strong>2009</strong><br />
Staff 7<br />
The remaining 3m was provided by Crédit Agricole PE. Th<strong>is</strong> transaction <strong>is</strong> the largest French series-A<br />
round of funding since 2005.<br />
Poxel will use the new funds <strong>to</strong> accelerate the development and clinical testing of its most advanced<br />
product, Imeglimine, designed <strong>to</strong> treat type-2 diabetes.<br />
Company<br />
Poxel span out from Merck Serono in <strong>2009</strong>. It develops anti-diabetic molecules, focusing particularly on<br />
treatment for type-2 diabetes. Poxel’s pipeline cons<strong>is</strong>ts of innovative products with original mechan<strong>is</strong>m<br />
of action, with an improved safety profile compared <strong>to</strong> currently available therapies. Based in Lyon,<br />
Poxel currently employs seven people.<br />
People<br />
Raphael W<strong>is</strong>niewski led the deal for EdRIP. CDC was represented by Thibaut Roulon. Bruno Montanari<br />
handled the transaction for Crédit Agricole. W<strong>is</strong>niewski and Montanari will join Poxel’s board, along<br />
with Olivier Martinez from the InnoBio fund. Thomas Kuhn <strong>is</strong> CEO of Poxel.<br />
Adv<strong>is</strong>ers<br />
Equity – Orsay, Frédéric Lerner, Lou<strong>is</strong> d’Urzo (Legal); HBC Avocats, Jonathan Burnham (Legal);<br />
Adwelsen, Florent Béliard (Financial due diligence); Régimbeau, Isabelle Mendelsohn (Intellectual<br />
property due diligence).<br />
Company – Bignon Lebray, Guy de Foresta (Legal); Bionest (Other due diligence).<br />
Sofinnova et al. back McPhy with 13.7m<br />
Transaction<br />
Sofinnova Partners, Gimv and Amundi Private Equity have backed McPhy Energy with a 13.7m<br />
second round of funding, alongside h<strong>is</strong><strong>to</strong>ric inves<strong>to</strong>rs.<br />
The company had already ra<strong>is</strong>ed a 1.6m first round of financing in January <strong>2009</strong> from Emertec and<br />
Areva. The new funds will be used for the global expansion of McPhy and the further industrial<strong>is</strong>ation<br />
and commercial<strong>is</strong>ation of its products. Already present in Spain and Italy, the company also plans <strong>to</strong><br />
expand in<strong>to</strong> Germany, northern Europe, the Middle East and Japan.<br />
EARLY-STAGE<br />
McPhy Energy<br />
13.7m<br />
Location La Motte-Fanjas<br />
Sec<strong>to</strong>r Renewable<br />
energy<br />
equipment<br />
Founded 2008<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 17<br />
www.unquote.com/france
early-stage<br />
unquote<br />
McPhy’s cleantech focus was a major attraction for the inves<strong>to</strong>rs. The deal marks Sofinnova’s fourth<br />
investment in th<strong>is</strong> sec<strong>to</strong>r, following its funding of DNP Green, Revolt Technology and Neosens.<br />
All contribu<strong>to</strong>rs <strong>to</strong> th<strong>is</strong> round believe solid state hydrogen s<strong>to</strong>rage will address the crucial <strong>is</strong>sue of<br />
sustainable energy s<strong>to</strong>rage.<br />
Company<br />
McPhy <strong>is</strong> a French company founded in January 2008 <strong>to</strong> industrial<strong>is</strong>e and commercial<strong>is</strong>e a new<br />
technology for the solid s<strong>to</strong>rage of hydrogen, in the form of magnesium hydride. The technology<br />
addresses the merchant hydrogen and renewable energy markets.<br />
McPhy owns exclusive rights on a portfolio of unique patents, which results from more than eight <strong>year</strong>s<br />
of research at the CNRS and CEA, in partnership with Joseph Fourier University.<br />
People<br />
Alessio Beverina led the deal for Sofinnova. Bart Diels handled the transaction for Gimv. Florent<br />
Thomann represented Amundi PEF. Pascal Mauberger <strong>is</strong> CEO of McPhy.<br />
Adv<strong>is</strong>ers<br />
Company – Clipper<strong>to</strong>n Finance, Nicolas von Bulow, Thomas Neveux (M&A).<br />
EARLY-STAGE<br />
EyeTechCare<br />
7.5m<br />
Location<br />
Sec<strong>to</strong>r<br />
Founded 2008<br />
Staff 7<br />
Rillieux-la-Pape<br />
Medical<br />
equipment<br />
Crédit Agricole et al. in 7.5m EyeTechCare deal<br />
Transaction<br />
Crédit Agricole Private Equity and insurance company SHAM have provided medical devices developer<br />
EyeTechCare with a 7.5m round of funding.<br />
Crédit Agricole led the round with 4.5m, while SHAM invested 3m. EyeTechCare had already<br />
ra<strong>is</strong>ed 1.2m in 2008 from Crédit Agricole and CEA-Invest<strong>is</strong>sement. The new funds will be used <strong>to</strong><br />
complete the initial clinical trials on humans, as well as <strong>to</strong> establ<strong>is</strong>h the manufacturing facilities and sales<br />
and marketing force required for the company’s first product.<br />
The inves<strong>to</strong>rs believe EyeTechCare’s solution will respond <strong>to</strong> unmet needs in the treatment of glaucoma.<br />
Crédit Agricole, which has been following the company since its inception, was particularly impressed<br />
with the management team’s progress over the last two <strong>year</strong>s.<br />
Company<br />
EyeTechCare was founded in 2008 and <strong>is</strong> based in Rillieux-la-Pape, near Lyon. With a staff of seven<br />
researchers, it special<strong>is</strong>es in non-invasive therapeutic medical devices using ultrasound technology. The<br />
company <strong>is</strong> currently developing an ultrasound-based medical device for the treatment of glaucoma; its<br />
market launch <strong>is</strong> scheduled for early 2011.<br />
People<br />
Alexia Perouse handled the transaction for Crédit Agricole. Olivier Szymkowiak represented SHAM.<br />
Fabrice Romano <strong>is</strong> the chairman of EyeTechCare.<br />
Adv<strong>is</strong>ers<br />
Equity – Morgan Lew<strong>is</strong> Bockius (Legal).<br />
Company – MAGS (Legal); Aelios Finance (Corporate finance).<br />
18 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
expansion<br />
Expansion capital <strong>is</strong> provided <strong>to</strong> support the growth and expansion of an establ<strong>is</strong>hed company and must include an element of equity financing.<br />
Funds may be used <strong>to</strong> enable increased production capacity, market or product development and/or <strong>to</strong> provide additional working capital.<br />
Acqu<strong>is</strong>ition finance provided <strong>to</strong> a new or ex<strong>is</strong>ting investee company <strong>to</strong> support its acqu<strong>is</strong>ition of a target or targets <strong>is</strong> also included in th<strong>is</strong> section.<br />
Butler invests 15m in Chr<strong>is</strong>tian Bernard<br />
Transaction<br />
Butler Capital has invested 15m in French jeweller Groupe Chr<strong>is</strong>tian Bernard, acquiring slightly less<br />
than 50% of the company.<br />
The company’s founding shareholders retain the remaining stake. Butler was attracted by Chr<strong>is</strong>tian<br />
Bernard’s position in the French jewellery market. The fresh capital will be used <strong>to</strong> accelerate the<br />
company’s international expansion.<br />
Company<br />
Chr<strong>is</strong>tian Bernard was founded in 1973 and launched its first collection in 1976. The company<br />
designs, manufactures and d<strong>is</strong>tributes watches and jewellery under its own name and through licensing<br />
partnerships. In 2005, the company purchased the retail chain Oro Vivo <strong>to</strong> directly sell its products in<br />
Germany, Switzerland, Spain and Portugal. Chr<strong>is</strong>tian Bernard has also expanded <strong>to</strong> Asia <strong>to</strong> manufacture<br />
some of its products and d<strong>is</strong>tribute them in local markets.<br />
EXPANSION<br />
Groupe Chr<strong>is</strong>tian<br />
Bernard<br />
15m<br />
Location Par<strong>is</strong><br />
Sec<strong>to</strong>r Clothing &<br />
accessories<br />
Founded 1973<br />
Turnover 150m (<strong>2009</strong>)<br />
Staff c4,000<br />
The group currently employs 4,000 staff and posted a 150m turnover in <strong>2009</strong>, 60% of which was<br />
generated outside of France. More than half of its sales are made through wholesale, while 45% <strong>is</strong><br />
through the retail market.<br />
People<br />
Pierre Costes and Frédéric Favreau led the deal for Butler. Damien Verrier <strong>is</strong> chief executive of Chr<strong>is</strong>tian<br />
Bernard.<br />
Adv<strong>is</strong>ers<br />
Equity – CGR Legal, Philippe Raybaud (Legal); Duff & Phelps, Sophie Moreau, Cédric Hetzel<br />
(Financial due diligence).<br />
Company – Murène, Dinah Emsalem (M&A); UGGC, Charles-Emmanuel Prieur, Laura Malach<br />
(Legal).<br />
123Venture invests in Redman Promotion<br />
Transaction<br />
123Venture has provided real estate company Redman Promotion with a first round of fundra<strong>is</strong>ing.<br />
The size of the investment has not been d<strong>is</strong>closed, but has been confirmed as less than 10m. The<br />
funds will be used <strong>to</strong> create two new subsidiaries for Redman – one focused on office buildings and<br />
the other on residential housing – with the ambition of launching 10 additional real estate operations.<br />
123Venture saw potential in Redman’s project due <strong>to</strong> a shortage of housing in France.<br />
EXPANSION<br />
Redman Promotion<br />
expansion<br />
unquote<br />
marketing and negotiation ass<strong>is</strong>tance. While th<strong>is</strong> <strong>is</strong> done for external promoters, Redman also manages<br />
its own portfolio through its Promotion branch. Operating out of Par<strong>is</strong> and Aix-en-Provence, Redman<br />
employs 12 people and generated a turnover of 5m in <strong>2009</strong>.<br />
People<br />
Eric Philippon handled the investment for 123Venture. Nicolas Ponson <strong>is</strong> founding partner and<br />
manager of Redman.<br />
Adv<strong>is</strong>ers<br />
Equity – Reed Smith, Stéphane Illouz (Legal).<br />
EXPANSION<br />
Oxat<strong>is</strong><br />
4m<br />
Location Marseilles<br />
Sec<strong>to</strong>r Internet<br />
Founded 2001<br />
Staff 40<br />
Crédit Agricole PE et al. invest 4m in Oxat<strong>is</strong><br />
Transaction<br />
Crédit Agricole Private Equity and A Plus Finance have provided 4m for e-commerce solutions<br />
provider Oxat<strong>is</strong>. Crédit Agricole PE will provide 2.5m, while previous inves<strong>to</strong>r A Plus Finance will<br />
give a further 1.5m. A Plus previously invested 1.33m in the company in 2008.<br />
The new funds will be used <strong>to</strong> enhance Oxat<strong>is</strong>’ software platform and offer its programme <strong>to</strong> other<br />
relevant businesses. The company also plans <strong>to</strong> quickly bolster its team, from 40 staff <strong>to</strong> more than<br />
100. The Crédit Agricole team was attracted by Oxat<strong>is</strong>’ product and the robustness of its business<br />
model. It also believes Oxat<strong>is</strong> caters <strong>to</strong> a growing need among French SMEs <strong>to</strong> set up their own<br />
merchant sites.<br />
Company<br />
Establ<strong>is</strong>hed in 2001 by Marc Schillaci, Oxat<strong>is</strong> provides cloud-computing e-commerce platforms<br />
for around 6,500 clients. Its technology enables SMEs, craftsmen and merchants <strong>to</strong> incorporate e-<br />
commerce software in<strong>to</strong> their websites. The company also enables businesses <strong>to</strong> get started on the<br />
internet and sell more without large set-up costs and long-term contracts. One in three e-commerce<br />
websites in France uses the Oxat<strong>is</strong> platform.<br />
People<br />
Renaud Poulard and Franco<strong>is</strong>-Xavier Dedde led the deal for Crédit Agricole. A Plus was represented<br />
by Niels Court-Payen, Jean-Michel Pimont and Alexandre Villet. Marc Schillaci <strong>is</strong> chairman of Oxat<strong>is</strong>’<br />
executive board.<br />
EXPANSION<br />
Nuxeo<br />
$3.3m<br />
Location Par<strong>is</strong><br />
Sec<strong>to</strong>r Software<br />
Founded 2000<br />
Turnover 3m<br />
Adv<strong>is</strong>ers<br />
Equity – Gide Loyrette Nouel, Pierre Karpik (Legal); Ernst & Young, Emmanuel Picard, Franco<strong>is</strong><br />
Poncet (Financial due diligence).<br />
Company – Kahn & Associés, Marie-Laure de Cordovez (Legal); Global Equities, Pascal Mercier,<br />
Guillaume Teboul (Corporate finance).<br />
OTC injects $3.3m in<strong>to</strong> Nuxeo<br />
Transaction<br />
OTC Asset Management has provided content management solutions provider Nuxeo with $3.3m.<br />
OTC previously invested $2.6m in late 2008, for a 41% stake in the company. The private equity house<br />
20 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
expansion<br />
renewed its backing after a successful launch in North America and says it <strong>is</strong> convinced by Nuxeo’s<br />
business model and positioning.<br />
The new capital will support a range of partner activities, such as funding co-development of thirdparty<br />
packaged applications, sharing Nuxeo’s engineering and services resources, and joint marketing<br />
and product launch activities. Nuxeo also plans <strong>to</strong> continue its expansion in North America with the<br />
hire of staff responsible for managing and expanding the Nuxeo Galaxy partner programme.<br />
Company<br />
Nuxeo <strong>is</strong> a provider of open-source content management solutions. It <strong>is</strong> headquartered in Par<strong>is</strong>, with<br />
offices in Bos<strong>to</strong>n, Madrid, Rome, Moscow and Dubai, and used by hundreds of companies worldwide,<br />
including the Press Association, Agence France Presse (AFP), Ell<strong>is</strong>Don and Cengage. The company<br />
generates revenue from its Nuxeo Galaxy partner programme, compr<strong>is</strong>ed of systems integra<strong>to</strong>rs,<br />
consultants and application solution providers who build content-centric applications on the company’s<br />
open-source technology. Founded in 2000, Nuxeo posted a 3m turnover for <strong>2009</strong>.<br />
People<br />
Patrick de Roquemaurel led the transaction for OTC and sits on the Nuxeo board. Eric Barroca <strong>is</strong> the<br />
CEO of Nuxeo.<br />
Adv<strong>is</strong>ers<br />
Equity – Gide Loyrette Nouel, Pierre Karpik (Legal).<br />
Company – Cabinet Joffe et Associés, Virginie Belle (Legal).<br />
BNP Paribas backs Acropol<strong>is</strong> with 1.8m<br />
Transaction<br />
BNP Paribas Private Equity has invested a further 1.8m in French telecoms opera<strong>to</strong>r Acropol<strong>is</strong><br />
Telecom. Th<strong>is</strong> <strong>is</strong> the second time BNP Paribas has backed the company, having initially invested<br />
700,000 in May <strong>2009</strong>.<br />
EXPANSION<br />
Acropol<strong>is</strong> Telecom<br />
1.8m<br />
Location Bagnolet<br />
Sec<strong>to</strong>r Internet<br />
Founded 2001<br />
Turnover 5m<br />
Staff 42<br />
The equity was drawn from Antin Proximité 1, Antin Proximité 2 and Antin Proximité 3 funds.<br />
The fresh capital will allow the company <strong>to</strong> continue its growth plans, including acqu<strong>is</strong>itions in the<br />
French market in order <strong>to</strong> increase its national presence. Additionally, Acropol<strong>is</strong> will look <strong>to</strong> grow<br />
organically by focusing on its offerings in the field of fixed and mobile telephony convergence and IT,<br />
as well as unified mail services.<br />
Company<br />
Establ<strong>is</strong>hed in 2001 by Samie Koleilat, Acropol<strong>is</strong> <strong>is</strong> a private network opera<strong>to</strong>r that focuses on corporate<br />
VPN MPLS and voice-over IP services.<br />
The company also offers internet access via both LAN and WAN, as well as security applications including<br />
firewalls, filters and anti-virus detec<strong>to</strong>rs. The business has partnerships with the likes of Cegetel, T Systems<br />
and France Telecom, and cus<strong>to</strong>mers in London, Amsterdam and Frankfurt. With a workforce of 42<br />
people, the company generated a turnover of 5m in <strong>2009</strong> – an increase of 25% on the previous <strong>year</strong>.<br />
People<br />
Managing partner Brice Lionnet and associate Laurent Bodino handled the investment for BNP Paribas.<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 21<br />
www.unquote.com/france
expansion<br />
unquote<br />
Adv<strong>is</strong>ers<br />
Equity – CPNC Avocats, Nicolas Chaigneau (Legal)<br />
EXPANSION<br />
Novapost<br />
1.7m<br />
Location<br />
Sec<strong>to</strong>r<br />
Founded 2007<br />
Staff 20<br />
Par<strong>is</strong><br />
Financial<br />
admin<strong>is</strong>tration<br />
Alven Capital et al. back Novapost with 1.7m<br />
Transaction<br />
Alven Capital, Fa Dièse and four individual inves<strong>to</strong>rs have injected 1.7m in<strong>to</strong> electronic HR solutions<br />
provider Novapost.<br />
The stakes taken by each contribu<strong>to</strong>r remain und<strong>is</strong>closed. It <strong>is</strong> the first investment Alven has made in<br />
Novapost, while business angels Gérard Pluvinet, Pierre Kosciusko-Morizet, Bruno Gueninand and<br />
Jean-Paul Villot are all ex<strong>is</strong>ting shareholders.<br />
Alven Capital was attracted by Novapost’s recent commercial achievements and its position in a<br />
growing market. The company has taken advantage of a recently-introduced French law that legal<strong>is</strong>ed<br />
the dematerial<strong>is</strong>ation of admin<strong>is</strong>trative documents. Following the investment, Novapost will look <strong>to</strong><br />
diversify its activity.<br />
Company<br />
Novapost, created in 2007, offers companies and individuals an alternative <strong>to</strong> paper mail and paper<br />
archives through a 100% electronic mailing system, guaranteeing the legal value of HR documents. By<br />
using the latest SaaS (Software as a Service) platform technologies, Novapost guarantees the security,<br />
traceability and 24/7 access <strong>to</strong> the clients’ key documents.<br />
The company has recently signed contracts with businesses such as M6, Athome, Canal+, Officeo,<br />
Groupe Batigère, Ub<strong>is</strong>oft, PriceMin<strong>is</strong>ter and Veolia Propreté, as well as set up partnerships with e-Paye,<br />
HR Path and De Gamma.<br />
People<br />
Charles Le<strong>to</strong>urneur was in charge of the investment for Alven. Jonathan Benamou <strong>is</strong> the chairman and<br />
founder of Novapost.<br />
Adv<strong>is</strong>ers<br />
Equity – Didier & Levy, Thierry Levy-Mannheim (Legal); Oder<strong>is</strong> Consulting, Guillaume Lauilhé,<br />
Vincent Texier (Financial due diligence).<br />
Company – FTPA, Nathalie Younan (Legal).<br />
EXPANSION<br />
Devederm<br />
1.4m<br />
Location<br />
Charbonnièresles-Bains<br />
Personal products<br />
Sec<strong>to</strong>r<br />
Founded 2008<br />
Turnover 1m (<strong>2009</strong>)<br />
Staff 30<br />
Viver<strong>is</strong> et al. inject 1.4m in<strong>to</strong> Devederm<br />
Transaction<br />
Viver<strong>is</strong> Management and Promelys Participations have co-led a 1.4m round of fundra<strong>is</strong>ing for<br />
cosmetics company Devederm. Viver<strong>is</strong> and Promelys contributed 500,000 each, while Vatel Capital<br />
provided 107,000. The remainder of the round was funded by business angels.<br />
The new funds will be used <strong>to</strong> fuel the company’s organic growth by expanding the range<br />
of products on offer and by targeting more retailers. Devederm <strong>is</strong> also looking <strong>to</strong> expand its<br />
operations across Europe in the near future. By implementing th<strong>is</strong> strategy, the company <strong>is</strong> aiming<br />
22 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
expansion<br />
for its products <strong>to</strong> be d<strong>is</strong>tributed by 350 retailers (up from 250) and <strong>to</strong> become profitable by the<br />
end of the <strong>year</strong>.<br />
Company<br />
Devederm was co-founded in 2008 by two former employees of rival cosmetics company Bioderma.<br />
The company manufactures and d<strong>is</strong>tributes the Terra Humana brand of cosmetic products across 250<br />
pharmacies in France. Devederm sources organic and fair-trade ingredients <strong>to</strong> manufacture more than<br />
20 different products.<br />
Based in Charbonnières-les-Bains, near Lyon, Devederm currently employs 30 people and has posted<br />
a 1m turnover for <strong>2009</strong>.<br />
People<br />
El<strong>is</strong>abeth Bertelli, Bruno Paglia and Sophie Gaddacha led the deal for Viver<strong>is</strong>. Hervé Le<strong>to</strong>ublon and<br />
Luc Chermette handled the transaction for Promelys. Franco<strong>is</strong> Gerber and An<strong>to</strong>ine Herbinet were in<br />
charge of the deal at Vatel. Thierry Le Morvan <strong>is</strong> CEO of Devederm.<br />
Adv<strong>is</strong>ers<br />
Company & Equity – Cabinet Colbert, Den<strong>is</strong> Simon, Cécile Dessapt (Legal); Canny Cap, Jean<br />
de la Rochebrochard, Guillaume Anselin (Corporate finance); Avvens, Jean-Pierre Lazaro (Financial<br />
due diligence).<br />
ISAI et al. invest 1.25m in Covoiturage.fr<br />
Transaction<br />
ISAI and a Span<strong>is</strong>h individual inves<strong>to</strong>r have backed Comu<strong>to</strong>, which runs carpooling website Covoiturage.<br />
fr, with 1.25m. ISAI provided the majority of the equity.<br />
Th<strong>is</strong> <strong>is</strong> the maiden investment from ISAI’s first fund, ISAI Developpement. The vehicle reached its first<br />
close at 24m in April 2010. It was mainly backed by internet and software entrepreneurs, as well as<br />
some institutional inves<strong>to</strong>rs. ISAI aims <strong>to</strong> make 12 investments over a four-<strong>year</strong> period.<br />
EXPANSION<br />
Comu<strong>to</strong> (edi<strong>to</strong>r of<br />
Covoiturage.fr)<br />
1.25m<br />
Location Par<strong>is</strong><br />
Sec<strong>to</strong>r Internet<br />
Founded 2006<br />
Staff 15<br />
The new capital combined with ISAI’s involvement will help the company grow in France and Spain.<br />
Covoiturage.fr <strong>is</strong> also looking in<strong>to</strong> various expansion opportunities, including further international<br />
deployment, diversification of its online services and strengthening of its B2B activities.<br />
Company<br />
Launched in 2004, Covoiturage.fr <strong>is</strong> a website that connects users looking for carpooling opportunities.<br />
Initially a side-project for its founders, the website became a corporate entity called Comu<strong>to</strong> in 2006.<br />
Travellers can input the details of their planned trip and contact drivers available for car-sharing who<br />
match those requirements.<br />
The website also acts as a social network where users can share their carpooling s<strong>to</strong>ries, post pictures<br />
and rate each other. Covoiturage.fr recently launched a mobile application, and <strong>to</strong>day represents 80%<br />
of all online carpooling ads in France with 600,000 reg<strong>is</strong>tered users.<br />
People<br />
Didier Kuhn and Pierre-Kosciusko-Morizet led the deal for ISAI. They are joining the company’s<br />
strategic committee. Frédéric Mazzella <strong>is</strong> the founder of Covoiturage.fr.<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 23<br />
www.unquote.com/france
expansion<br />
unquote<br />
EXPANSION<br />
FInteractive<br />
500,000<br />
Location Lyon<br />
Sec<strong>to</strong>r Media agencies<br />
Founded 2007<br />
Turnover 600,000 (2008)<br />
Staff 11<br />
Adv<strong>is</strong>ers<br />
Equity – Gide Loyrette Nouel, Annabelle Raguenet de Saint Albin (Legal); 2C Finance, Frank<br />
Chuffard (Financial due diligence); Proskauer, Etienne Mathey (Tax).<br />
Company – Mo<strong>is</strong>and Boutin & Associés, Jean-Philippe Jacob, Harold Forestier (Legal); Carbonnier<br />
Lamaze Rasle & Associés, Charles Delavenne (Legal).<br />
Vatel supports FLInteractive with 500,000<br />
Transaction<br />
Vatel Capital has injected 500,000 of equity in<strong>to</strong> French online marketing agency FLInteractive. The<br />
company’s founder and management retain a majority stake, and Vatel’s stake has not been d<strong>is</strong>closed.<br />
The funds will be used <strong>to</strong> sustain the business’s growth by acquiring new clients and studying possible<br />
acqu<strong>is</strong>ition opportunities, with the aim of becoming a strong player in the free online gaming market.<br />
The deal was initiated through Canny Cap on behalf of the company.<br />
Company<br />
FLInteractive focuses its core activity on website publ<strong>is</strong>hing and online marketing. It offers a range of<br />
solutions for qualified database acqu<strong>is</strong>ition, co-reg<strong>is</strong>tration services, emailing campaigns and cost-perclick<br />
marketing. Founded in 2007 by Frédéric Lampin and Guillaume Ferrand, the company currently<br />
employs 11 staff and <strong>is</strong> based in Lyon.<br />
People<br />
Franco<strong>is</strong> Gerber and An<strong>to</strong>ine Herbinet handled the transaction for Vatel. Frédéric Lampin and<br />
Guillaume Ferrand are the founders and managers of FLInteractive.<br />
EXPANSION<br />
Intégral Système<br />
unquote<br />
expansion<br />
The company <strong>is</strong> based in Emerainville and employs 20 staff. It posted a 4.2m turnover in <strong>2009</strong>, up<br />
2% from the previous <strong>year</strong>.<br />
People<br />
Isabelle Galamand-Patard represented Avenir on the transaction. Stéphane Mélinand-Jégou <strong>is</strong> CEO of<br />
Intégral Système.<br />
Adv<strong>is</strong>ers<br />
Equity – PDGB, Roy Arakelian, Madia Iliopoulos (Legal).<br />
Company – Cabinet Quesnel-Hesters, Nicole Quesnel-Hesters (Legal).<br />
AXA’s Kall<strong>is</strong>ta Energy acquires four windfarms<br />
Transaction<br />
Kall<strong>is</strong>ta Energy has acquired the Brittany wind farm assets of Neoelectra, with the support of AXA<br />
Private Equity. The amount of expansion capital provided by AXA remains confidential.<br />
AXA wholly acquired Kall<strong>is</strong>ta Energy (formerly Holding Energies Renouvelables) from Babcock &<br />
Brown in <strong>2009</strong>, for an estimated value of 100-250m. The acqu<strong>is</strong>ition consolidates Kall<strong>is</strong>ta’s position in<br />
the French market, by increasing the number of its wind farms from 15 <strong>to</strong> 19 and its installed capacity <strong>to</strong><br />
194.5 MW. It also allows the company <strong>to</strong> be present in Brittany, a region with a particularly high potential<br />
for wind-produced energy.<br />
ACQUISITION FINANCE<br />
Kall<strong>is</strong>ta Energy<br />
Location Par<strong>is</strong><br />
Sec<strong>to</strong>r Renewable<br />
energy<br />
equipment<br />
Founded <strong>2009</strong><br />
Turnover 26.1m (<strong>2009</strong>)<br />
Staff 10<br />
Company<br />
Kall<strong>is</strong>ta Energy was founded in <strong>2009</strong> when AXA wholly acquired Kall<strong>is</strong>ta Energies Renouvelables<br />
(formerly Eners<strong>is</strong> Energies Renouvelables) and Kall<strong>is</strong>ta France (formerly Eners<strong>is</strong> France). The two<br />
companies were held through Holding Energies Renouvelables, which was renamed Kall<strong>is</strong>ta Energy in<br />
November <strong>2009</strong>. The company manufactures and operates wind farms.<br />
Based in Par<strong>is</strong>, the business has a significant presence in the A<strong>is</strong>ne/Picardie, Beauce and Seine-Maritime<br />
regions. With a 10-strong workforce, Kall<strong>is</strong>ta Energy posted a 26.1m turnover in <strong>2009</strong>.<br />
People<br />
Mathias Burghardt led the deal for AXA. Frédéric Roche <strong>is</strong> the CEO of Kall<strong>is</strong>ta Energy.<br />
Adv<strong>is</strong>ers<br />
Acquirer – CGR Legal, Florence Trognon-Dumain (Legal); Linklaters, Edouard Chapellier<br />
(Financial due diligence); Exco A2A, Franck Huyghe (Tax).<br />
Vendor – Freshfields Bruckhaus Deringer, Bertrand Pellet, Gabriel Flandin, Basma Paradin (Legal);<br />
Natix<strong>is</strong> Finance, Emmanuel Antmann (M&A).<br />
www.unquote.com/france<br />
The new home of private equity news, data and analys<strong>is</strong><br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 25<br />
www.unquote.com/france
uyouts<br />
unquote<br />
Leveraged buyouts and buy-ins involving equity investments by formal<strong>is</strong>ed private equity inves<strong>to</strong>rs through the formation of a newco based<br />
in France.<br />
SECONDARY BUYOUT<br />
Thermocoax<br />
Location Flers<br />
Sec<strong>to</strong>r Industrial<br />
suppliers<br />
Founded 1957<br />
Turnover 35m<br />
Staff 200<br />
Chequers buys Thermocoax back from TCR<br />
Transaction<br />
Chequers Capital has purchased a 60% stake in heating technology special<strong>is</strong>t Thermocoax from TCR<br />
Capital for an und<strong>is</strong>closed amount.<br />
TCR retains a 30% stake in the business through its TCR Capital Partners II fund. The remaining 10%<br />
of the shares are now owned by the management team, led by CEO Claude Capron.<br />
Th<strong>is</strong> represents the fourth time the company has been acquired by a private equity inves<strong>to</strong>r.<br />
Debt<br />
A 35m senior debt was co-led by CIC and LCL, with the support of BCME and Banques Populaires<br />
de l’Ouest. Indigo arranged the 11m mezzanine facility.<br />
Previous funding<br />
In 1998, Thermocoax was initially sold <strong>to</strong> Advent International by Phillips Electronics as part of the<br />
divestiture of a larger div<strong>is</strong>ion. Chequers backed the management buyout of the company in 2000 <strong>to</strong><br />
gain a 75% shareholding. TCR then acquired 85% of the firm in 2005 for an estimated 35m. The<br />
latest sale sees TCR reap an estimated 5x on its 2005 investment.<br />
Under TCR’s ownership, the company has expanded internationally and now operates out of Germany,<br />
the UK, the Netherlands and the US. It has also diversified its product offering <strong>to</strong> generate growth<br />
across a range of different industries.<br />
Company<br />
Thermocoax span out from Philips Electronics in 1957 under the name of SODERN (Société Anonyme<br />
d’Etudes & Réal<strong>is</strong>ations Nucléaires) <strong>to</strong> market Thermocoax branded products <strong>to</strong> the nuclear industry.<br />
In 1982, the company opened a plant in Planquivon, Normandy, and was renamed Thermocoax.<br />
It currently designs and manufactures heating systems and temperature sensors, targeting nuclear<br />
energy and aeronautical applications, as well as semi-conduc<strong>to</strong>r and medical equipment manufacturers.<br />
With a 200-strong staff, Thermocoax posted a 35m turnover for <strong>2009</strong>, 80% of which comes from<br />
international markets.<br />
People<br />
Guillaume Planchon and Aurélien Klein led the deal for Chequers. David Robin, Chr<strong>is</strong>tian Dorléac and<br />
Fabien Bernez represented TCR on the transaction. David Robin will keep h<strong>is</strong> seat on the company’s<br />
board. Claude Capron <strong>is</strong> the CEO of Thermocoax.<br />
Adv<strong>is</strong>ers<br />
Acquirer – Mayer Brown, Guillaume Kuperfils, Pascal Druhen-Chanaux, Laure Canu (Legal);<br />
Laurent Borey, Jérémie Thézée, Julie Barbier (Tax); Jean-Philippe Lambert, Patrick Teboul (Debt);<br />
CMI, Lubomir Mortchev (Commercial due diligence); Oder<strong>is</strong>, Guillaume Lauilhé, Julien Passerat<br />
(Financial due diligence); Fidal, Jean-Pascal Amoros, Caroline Ackermann (Legal, financial and social<br />
due diligence).<br />
26 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
buyouts<br />
Vendors – UBS, Fabrice Scheer, Arnaud Fauqueur, Erwan Meurzec (Corporate finance); Paul<br />
Hastings, Olivier Deren, Mathias Roth, Mounir Letayf (Legal); Allard de Waal, Laurent Ragot<br />
(Tax); Ernst & Young, Emmanuel Picard (Financial due diligence); ADL, Vincent Bamberger<br />
(Market due diligence).<br />
Debt – Gide Loyrette Nouel, Chucri Serhal (Legal).<br />
ERCP backs Hyper Embal and Valeurd<strong>is</strong> MBO<br />
Transaction<br />
Edmond de Rothschild Capital Partners (ERCP) has taken a 60% stake in Financière HEVD, the<br />
holding company of merged French firms Hyper Embal and Valeurd<strong>is</strong>.<br />
The remaining 40% <strong>is</strong> now owned by the companies’ management teams. The overall value of the MBO<br />
has not been d<strong>is</strong>closed, but ERCP provided close <strong>to</strong> 10m of equity. Th<strong>is</strong> <strong>is</strong> the fifth investment from<br />
ERCP’s ERLF II fund.<br />
MBO<br />
Hyper Embal/Valeurd<strong>is</strong><br />
Founded 1990/1994<br />
Location Seclin/Gravigny<br />
Sec<strong>to</strong>r Containers and<br />
packaging<br />
Turnover 100m<br />
(combined)<br />
The involvement of ERCP <strong>is</strong> hoped <strong>to</strong> accelerate the merger of the two companies and lead <strong>to</strong> a strengthened<br />
position in the French market. The consolidated structure will generate a turnover of around 100m.<br />
Debt<br />
Senior debt was co-led by Société Générale and Crédit du Nord, with the support of Banque<br />
Populaire du Nord and LCL. The prec<strong>is</strong>e amount was not d<strong>is</strong>closed but <strong>is</strong> around 3x the companies’<br />
consolidated EBITDA.<br />
Company<br />
Hyper Embal and Valeurd<strong>is</strong> both special<strong>is</strong>e in packaging for large food retailers. Hyper Embal <strong>is</strong> based<br />
in the north of France and focuses on breadbags and packaging for fresh products, of which it currently<br />
s<strong>to</strong>cks more than 2,600.<br />
Normandy-based Valeurd<strong>is</strong> d<strong>is</strong>tributes shopping bags and d<strong>is</strong>posable cutlery, sourced in Europe and<br />
Asia. Both companies generated a <strong>2009</strong> turnover close <strong>to</strong> 50m.<br />
People<br />
Erick Fouque, Olivier Dubs and Marie Londero led the deal for ERCP. Alain Flitz <strong>is</strong> the CEO of Hyper<br />
Embal. Daniel Guibert <strong>is</strong> the CEO of Valeurd<strong>is</strong>.<br />
Adv<strong>is</strong>ers<br />
Equity – Hoche Société d’Avocats, Jean-Luc Blein, Laurent Bensaid, Marie Peyréga (Legal and<br />
tax); KPMG, Axel Rebaudières, Guillaume Monin (Financial due diligence); Diligence Partners,<br />
Delphine Mathez, Nicolas Moulin-Fournier (Strategic due diligence).<br />
Vendor – Fidac, Frédéric Frésiers (Legal).<br />
NextStage backs Groupe ACR MBO with 8.2m<br />
Transaction<br />
NextStage has provided 8.2m <strong>to</strong> back the partial buyout of spare au<strong>to</strong> parts d<strong>is</strong>tribu<strong>to</strong>r Groupe<br />
ACR. The investment – effectively part buyout and part growth funding – was performed mostly<br />
MBO<br />
Groupe ACR<br />
Location Gennevilliers<br />
Sec<strong>to</strong>r Au<strong>to</strong> parts<br />
Founded 1993<br />
Turnover 40m<br />
Staff 115<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 27<br />
www.unquote.com/france
uyouts<br />
unquote<br />
through the FCPR NextStage PME Championnes II fund, in conjunction with four other NextStage<br />
FIP funds.<br />
It allows the private equity firm <strong>to</strong> secure a significant minority stake in the company (30-50%). The<br />
remainder of the shares are now owned by ACR’s management. One of the company’s founders has<br />
exited the business.<br />
NextStage was attracted by the company’s focus on innovation, as well as its record of sustained growth<br />
throughout the past decade (+20% per annum since 2001). The new funds and the presence of a<br />
recogn<strong>is</strong>ed financial backer will help ACR finance its expansion across France and develop its “H+4”<br />
rapid delivery service.<br />
Debt<br />
LCL and Société Générale provided banking facilities, which account for a small amount of the overall<br />
investment.<br />
Company<br />
Founded in 1993, Groupe ACR special<strong>is</strong>es in the d<strong>is</strong>tribution of spare au<strong>to</strong> parts. It compr<strong>is</strong>es two<br />
branches: ACR, which focuses on braking and general chass<strong>is</strong> parts; and Autec, which special<strong>is</strong>es in<br />
starters and alterna<strong>to</strong>rs. Based in Gennevilliers, the group employs 115 people and posted a 40m<br />
turnover for <strong>2009</strong>.<br />
People<br />
Nicolas de Saint Etienne and Aloys de Fontaines led the deal for NextStage. Jean Rousseau <strong>is</strong> co-founder<br />
and chairman of ACR, while Samuel Denos <strong>is</strong> CEO of the company. Vincent Tornamorell and Karine<br />
Bruggeman represented LCL, while Adrien Bagard was in charge of the transaction for Société Générale.<br />
Adv<strong>is</strong>ers<br />
Equity – CMS Bureau Franc<strong>is</strong> Lefebvre, Arnaud Hugot, Virginie Corbet-Picard (Legal); CDA,<br />
Fabrice Capo<strong>to</strong>s<strong>to</strong> (Tax); Mazars, Pierre Tcher<strong>to</strong>ff, Luc Chambon (Financial due diligence).<br />
Company – Cotty Vivant March<strong>is</strong>io & Lauzeral, Philippe Lauzeral, Franço<strong>is</strong> Brocard, Marie Nezam<br />
(Legal); Franck Le Mentec (Tax); Cro<strong>is</strong>sance Partenaires, Pierre Miallot, Julien Jeremie, Charles<br />
Huyghes Despointes (M&A).<br />
exits<br />
TRADE SALE<br />
PriceMin<strong>is</strong>ter<br />
c200m<br />
Location Par<strong>is</strong><br />
Sec<strong>to</strong>r Internet<br />
Founded 2001<br />
Turnover 40m<br />
EBIT 7m<br />
Staff >200<br />
Atlas Venture et al. sell shares in PriceMin<strong>is</strong>ter<br />
Transaction<br />
Japanese e-commerce special<strong>is</strong>t Rakuten has acquired a 100% stake in the PriceMin<strong>is</strong>ter group from<br />
Atlas Venture, Phillimore, Technocap, Quilvest and individual shareholders.<br />
The company was acquired by Rakuten’s European branch and <strong>is</strong> valued at around 200m. Private equity<br />
funds owned slightly more than 20% of the company prior <strong>to</strong> the sale. Atlas was the major private equity<br />
shareholder, closely followed by Quilvest, while Phillimore and Technocap (who had invested in the early<br />
stages) retained smaller stakes. Individual shareholdings and returns remain und<strong>is</strong>closed.<br />
28 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
exits<br />
The major fac<strong>to</strong>r in the sale’s timing was <strong>to</strong> allow private equity funds <strong>to</strong> exit. PriceMin<strong>is</strong>ter was<br />
originally on track for a successful IPO in early 2008 but, in the face of market turmoil, the owners<br />
chose <strong>to</strong> postpone and look for another means of exit.<br />
Rakuten, a Japanese e-commerce special<strong>is</strong>t, hopes the acqu<strong>is</strong>ition will help it establ<strong>is</strong>h itself in Europe<br />
after similar acqu<strong>is</strong>itions in China (Badoo) and the US (LinkShare). It was also attracted by France’s<br />
significant e-commerce growth rate of more than 25% per annum, compared <strong>to</strong> 15% for Japan. The new<br />
owner expects the company <strong>to</strong> expand its business in Spain and the UK, create subsidiaries and perform<br />
several acqu<strong>is</strong>itions in the future.<br />
Previous funding<br />
Technocap led a 1.8m first round of funding for the firm in 2001, alongside a syndicate of corporate<br />
and private inves<strong>to</strong>rs. 3i then led a 7m investment in PriceMin<strong>is</strong>ter back in 2005, alongside a syndicate<br />
compr<strong>is</strong>ing Quilvest and private inves<strong>to</strong>rs. After the PriceMin<strong>is</strong>ter acqu<strong>is</strong>ition of Mixad in 2007, Mixad<br />
backer Atlas Venture entered the equity syndicate through a share swap. 3i sold its stake <strong>to</strong> Quilvest, Atlas<br />
Ventures and the founders in November <strong>2009</strong>, making Atlas the largest private equity shareholder.<br />
Company<br />
Founded in 2001, PriceMin<strong>is</strong>ter started as an e-commerce website dedicated <strong>to</strong> linking buyers and sellers<br />
online and assuring the safety of the transaction for both parties. Since then, the group has expanded with<br />
several acqu<strong>is</strong>itions and <strong>to</strong>day compr<strong>is</strong>es www.pricemin<strong>is</strong>ter.com, travel price compar<strong>is</strong>on website www.<br />
voyagermoinscher.com and real-estate platform www.avendrealouer.fr, among other special<strong>is</strong>t websites.<br />
PriceMin<strong>is</strong>ter has more than 12 million reg<strong>is</strong>tered users. The group posted a 40m turnover and 7m<br />
EBIT for <strong>2009</strong> and employs more than 200 people.<br />
People<br />
Fred Destin led the deal for Atlas. Pierre Kosciusko-Morizet <strong>is</strong> the founder and CEO of PriceMin<strong>is</strong>ter;<br />
he will stay at h<strong>is</strong> post for a further five <strong>year</strong>s, along with the rest of the management. Hiroshi Mikitani<br />
<strong>is</strong> the founder and CEO of Rakuten.<br />
Adv<strong>is</strong>ers<br />
Company – Gide Loyrette Nouel, Pierre Karpik (Legal); Arma Partners, Eric Lawson-Smith<br />
(Corporate finance).<br />
Truffle Capital floats Carmat for 15.5m<br />
Transaction<br />
Artificial heart developer Carmat has completed its IPO on the Alternext of NYSE-Euronext Par<strong>is</strong>,<br />
ra<strong>is</strong>ing 15.5m. A <strong>to</strong>tal of 800,000 new shares have been <strong>is</strong>sued, representing 22.15% of the company’s<br />
capital. Shares were priced at 18.75. The IPO values Carmat at more than 75m.<br />
Truffle Capital now retains a 31.8% stake in Carmat. It <strong>is</strong> currently not considering a complete exit<br />
from the company, even after the 180-day lock-up period expires. The capital increase will be used <strong>to</strong><br />
finance the final<strong>is</strong>ation of pre-clinical testing, as well as the first clinical trials of Carmat’s artificial heart<br />
on humans. Carmat aims <strong>to</strong> complete these tests by 2011.<br />
IPO<br />
Carmat SAS<br />
75m<br />
Location<br />
Sec<strong>to</strong>r<br />
Founded 2008<br />
Staff 36<br />
Vélizy-<br />
Villacoublay<br />
Medical<br />
equipment<br />
Previous funding<br />
Truffle Capital co-founded Carmat and led its first round of financing with 5m in 2008. Aerospace<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 29<br />
www.unquote.com/france
exits<br />
unquote<br />
company EADS and the Fondation Alain Carpentier provided an additional 2.5m. French national<br />
agency for industrial innovation Oséo awarded the company with 33m in grants and loans.<br />
Company<br />
Carmat was created in 2008 as a spinout of the collaboration between Alain Carpentier and EADS.<br />
Its artificial human heart pro<strong>to</strong>type has been patented and <strong>is</strong> undergoing pre-clinical testing. It <strong>is</strong><br />
functionally similar <strong>to</strong> the human heart in both ana<strong>to</strong>mic and functional terms – notably via au<strong>to</strong>matic<br />
regulation of heart rate and blood flow according <strong>to</strong> the patient’s physiological needs. Meeting the<br />
human body’s biocompatibility criteria, Carmat’s device virtually eliminates the rejection <strong>is</strong>sues<br />
associated with traditional heart transplants.<br />
People<br />
Dr Philippe Pouletty led the IPO for Truffle Capital and sits on Carmat’s board. Marcello Conviti <strong>is</strong><br />
CEO of Carmat.<br />
EXIT<br />
Groupe Keria<br />
6-9m<br />
Location Echirolles<br />
Sec<strong>to</strong>r Durable<br />
household<br />
products<br />
Founded 1982<br />
Turnover 110m (<strong>2009</strong>)<br />
Siparex exits Keria<br />
Transaction<br />
Siparex has sold its entire minority stake in lighting products retailer Keria <strong>to</strong> the founding family.<br />
Previous funding<br />
Siparex invested 3m in 2000 through its SPF II fund and its l<strong>is</strong>ted vehicle Siparex Cro<strong>is</strong>sance, in<br />
exchange for less than 10% of the company’s shares. The private equity firm has announced a return on<br />
its initial investment of slightly more than 2x, which would value the sale at 6-9m.<br />
Keria has experienced sustained growth since Siparex’s initial investment; the company’s turnover has<br />
doubled and it now operates three times more outlets following a bolt-on acqu<strong>is</strong>ition in 2008. It <strong>is</strong> the<br />
first lighting products retailer in France and <strong>is</strong> looking at a possible international expansion.<br />
Company<br />
Founded in 1982, Keria <strong>is</strong> a lighting fixtures retailer based in Echirolles. Following the acqu<strong>is</strong>ition of<br />
Laurie Lumière in 2008, the group now operates 140 s<strong>to</strong>res, mainly located on the outskirts of various<br />
French cities. Keria posted a 110m turnover for <strong>2009</strong>.<br />
People<br />
Benoit Méta<strong>is</strong> led the Siparex team, which also compr<strong>is</strong>ed Thierry Candelier and Emmanuel Botzung.<br />
Marcel Barbe <strong>is</strong> the founder and chairman of the superv<strong>is</strong>ory board of Keria.<br />
EXIT<br />
Trecobat<br />
Location Lannil<strong>is</strong><br />
Sec<strong>to</strong>r Home<br />
construction<br />
Founded 1972<br />
Turnover c100m (<strong>2009</strong>)<br />
Staff 250<br />
Adv<strong>is</strong>ers<br />
Equity and company – Mes Louvat Vincent Cach Giraud Vancleemput Plottin, Ludovic<br />
Giraud (Legal).<br />
AXA Private Equity sells Trecobat stake<br />
Transaction<br />
AXA Private Equity has sold its 46.5% stake in home-building group Trecobat <strong>to</strong> the company’s<br />
management team. The amount of the sale remains confidential, but allowed AXA <strong>to</strong> reap a 3x multiple<br />
30 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
exits<br />
on its original investment, equating <strong>to</strong> an IRR of 45% per annum. The management team <strong>is</strong> now the<br />
new majority shareholder.<br />
AXA bought the company in 2007 for a price estimated <strong>to</strong> be in the 50-100m range. The private equity<br />
firm was sat<strong>is</strong>fied with the company’s performance despite the downturn; Trecobat’s gross margin has<br />
improved by seven points and the group has increased its market share from 10% <strong>to</strong> 15%. AXA also helped the<br />
management introduce a new corporate governance scheme and implement stronger financial reporting.<br />
Company<br />
Trecobat <strong>is</strong> a home-building group founded in 1972 by Marcel Treguer. Building more than 1,000 homes<br />
per <strong>year</strong>, the group <strong>is</strong> also present in the high-growth segment of timber housing under the “Ma<strong>is</strong>ons Nature<br />
et Bo<strong>is</strong>” brand, with more than 15% of its revenue earned from th<strong>is</strong> segment. It has recently focused part of<br />
its activity on low consumption housing. Based in Lannil<strong>is</strong>, Trecobat employs 250 people and operates in<br />
Brittany, as well as the Loire-Atlantique and the Toulouse regions. It posted a 100m turnover for <strong>2009</strong>.<br />
People<br />
Baudouin d’Hérouville, Alex<strong>is</strong> Lavaillote and Caroline Pihan represented AXA on the deal. Alban Boyé<br />
<strong>is</strong> the managing direc<strong>to</strong>r of Trecobat.<br />
Adv<strong>is</strong>ers<br />
Equity – De Pardieu Brocas Mafféi, Thibaut Caharel, Jean-Franço<strong>is</strong> Pourdieu (Legal).<br />
Management – SCM Juripro, Marcel Hascoet (Legal); Sofico, Michel Gouriten (Financial due<br />
diligence).<br />
EUROPEAN<br />
BUYOUT<br />
REVIEW 2010<br />
VALIDATED BUYOUT DATA.<br />
COMPREHENSIVE OVERVIEW<br />
OF THE BUYOUT MARKET.<br />
The 21st edition of the European Buyout Review provides you with a detailed<br />
analys<strong>is</strong> of the European buyout market from 2005-<strong>2009</strong>.<br />
V<strong>is</strong>it europeanbuyoutreview.com or call +44 (0)20 7484 9884 now for more<br />
information & <strong>to</strong> order your copy.<br />
unquotebooks.com
funds ra<strong>is</strong>ing<br />
unquote<br />
A Austria<br />
BE Belgium<br />
CH Switzerland<br />
D<br />
DEN<br />
EE<br />
Germany<br />
Denmark<br />
Es<strong>to</strong>nia<br />
EI<br />
ES<br />
F<br />
Ireland<br />
Spain<br />
France<br />
FIN Finland<br />
I Italy<br />
LT Lithuania<br />
Group Fund name Base Target (m) Close Closed on (m)<br />
123Venture 123Expansion II F n/d FA c20<br />
123Venture 123Multivova IV F n/d FA c15<br />
21 Centrale Partners 21 Centrale Partners IV F 500 2nd 300<br />
A Plus Finance A Plus Innovation 6 F n/d 1st 35<br />
Agro Invest Agro Plus F 150 1st 80<br />
Arcano Capital Global Opportunity Fund II ES 250 FA 0<br />
Argos Soditic Argos Expansion F 120 1st 45<br />
Ashmore Ashmore Global Special Situations Fund Five UK c$2,000 FA 0<br />
Aurel NextStage Aurel NextStage FCPR Champion Small Cap II F 120 1st 61<br />
Baigo Capital Baigo Capital D 300 1st 100<br />
BlackFin Capital Partners BlackFin Financial Services Fund F 300 1st 60<br />
Cathay Capital Cathay Capital I F 70 1st 50<br />
CEL Partners China Equity Links F 70 1st 43<br />
CIC LBO Partners CIC LBO Fund II F 250 1st 157<br />
DN Capital Global Venture Capital II UK 100 1st 50<br />
Efigestioni Efilog Private Equity I 50 FA 0<br />
Environmental Technologies Fund Environmental Technologies Fund UK 50 FA 0<br />
Finint & Partners NEIP II LX 120 1st 62<br />
Foundations Capital Foundations Capital F n/d 1st 150<br />
Fountain Healthcare Fountain Healthcare Partners 1 EI n/d 1st 75<br />
Gilde Buyout Partners Gilde Buyout Fund IV NL n/a FC 800<br />
Grand Ouest Gestion Ouest Ventures II F 30-50 1st 21<br />
I2BF Venture Fund II UK $100 FA 0<br />
Irdi-Icso IcsoII F 100 1st 64<br />
Kurma Life Science Partners Kurma Biofund F 75 1st 50<br />
LBO France Altercap F 150 FA 0<br />
LBO France Hexagone III F 180 1st n/d<br />
LFPI LFPI Mezzanine LX 300 FA 0<br />
Matignon Invest<strong>is</strong>sement & Gestion MT II F 100 1st 60<br />
Montefiore Investment Montefiore Investment II F n/d 2nd 250<br />
NBGI Private Equity France NBGI Private Equity France I F n/d 1st 50<br />
NBGI Ventures NBGI Technology Fund II UK 60 1st 30<br />
Oakley Capital Oakley Capital Private Equity Bermuda 550 1st n/d<br />
Occam Capital Occam I F 150 1st 35<br />
Ofi Private Equity Ofi Europa I F 100 1st 30<br />
SGAM AI Private Equity PME France Invest<strong>is</strong>sement II F 60 1st 15<br />
Siparex Siparex proximite III F 40 1st 15<br />
The Carlyle Group Carlyle Global Financial Services Partners US n/d FC 1,100<br />
UFG Private Equity Diadème Innovation III F 50 FA 0<br />
UFG Private Equity / Schroders Diadème Global Selection F 100 FA 0<br />
UI Gestion MI5 F 80-100 1st 50<br />
Unigestion Unigestion Environmental Sustainability CH $250 FA 0<br />
Unigestion Unigestion Secondary Opportunity Fund II CH $150 FA 0<br />
Vermeer Capital Vermeer Capital F 90 1st 75<br />
Vespa Capital Vespa 1 UK/F 100 1st 50<br />
WHEB Ventures Private Equity WHEB Ventures Private Equity 2 LP UK 150 4th 114<br />
32 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
LX<br />
NL<br />
NOR<br />
Luxembourg<br />
Netherlands<br />
Norway<br />
P<br />
PL<br />
SWE<br />
Portugal<br />
Poland<br />
Sweden<br />
UK<br />
US<br />
FA<br />
United Kingdom<br />
United States<br />
Fund announced<br />
FC<br />
1st<br />
2nd<br />
Fund closed<br />
First close<br />
Second close<br />
Date Stage Geographic Contact Telephone No.<br />
Feb-07 Expansion EU Olivier Goy +33 1 49 26 98 00<br />
Feb-07 Expansion EU Olivier Goy +33 1 49 26 98 00<br />
Mar-10 Buyout EU Gerard Pluvinet +33 1 56 88 33<br />
Feb-07 Early-stage F Niels Court-Payen +33 1 40 08 03 40<br />
Jul-07 Buyout, expansion F Jean-Lou<strong>is</strong> Ruatti +33 1 40 69 48 15<br />
May-08 Fund-of-funds Europe,Asia,US Ignacio Sarría +34 917 00 38 80<br />
Jul-10 Expansion - SMEs France Constance Jay +33 1 53 67 20 50<br />
Jul-08 Buyout, d<strong>is</strong>tressed debt Western Europe, US Mark Coombs, Jerome Booth +44 20 3077 6000<br />
Feb-09 Expansion EU Gregoire Sentilhes 33 1 53 93 49 40<br />
Nov-07 Buyout – mid-market Europe Marcus Bracklo +49 69 17 39 26 00<br />
Feb-10 Buyout, expansion Europe Laurent Bouyoux +33 1 75 00 02 32<br />
Jul-07 Expansion EU, China Mingpo Cai +33 1 42 25 28 00<br />
Apr-07 Expansion EU, China André Loesekrug-Pietri +33 6 85 31 51 59<br />
Nov-08 Buyout F Bertrand Fesneau +33 1 42 66 70 57<br />
May-08 Early-stage EU, US, CEE Nenad Marovac +44 20 7340 1600<br />
Mar-08 Buyout, expansion EU, Middle East, Asia Fabrizio Vet<strong>to</strong>si +39 02 85 86 99 00<br />
Feb-07 Early-stage, expansion EU Peter Horsburgh +44 207 734 1368<br />
Jul-07 Infrastructure EU Matteo Patrone +39 04 38 36 04 05<br />
May-08 Buyout – upper mid-market F Xavier Marin +33 1 55 35 55 00<br />
Jun-08 Early-stage – life sciences Europe A<strong>is</strong>ling Garvey +35 31 66 33 60 7<br />
Jun-10 Buyout – mid-market Europe Koos Teule +31 30 219 2508<br />
Nov-08 Expansion F Eric Cozanet + 33 0 2 99 35 04 00<br />
Apr-10 Cleantech Global Ilya Golubovich<br />
May-08 Buyout, expansion F Renaud du Lac +33 5 34 41 74 17<br />
Nov-09 Early-stage EU Alain Maiore, Thierry Laugel +33 1 58 19 20 53<br />
Apr-09 D<strong>is</strong>tressed debt F Elizabeth O’Reilly +33 1 40 62 76 06<br />
Feb-10 Buyout – Small-cap F Elizabeth O’Reilly +33 1 40 62 7606<br />
Jun-07 Mezzanine F, Western Europe Aimeric Ouaknine +33 1 58 36 44 90<br />
Oct-06 Early-stage, expansion EU, US Guillaume Connan +33 1 53 53 98 12<br />
Dec-08 Buyout, Expansion F Eric B<strong>is</strong>muth +33 1 58 18 68 68<br />
Jul-09 Buyout, expansion F Laurent Allegot +33 1 58 56 18 95<br />
Nov-07 Early-stage Europe Ar<strong>is</strong> Constantinides +44 207 661 5656<br />
Nov-07 Buyout – mid-market Europe Peter Dubens, David Boyd +44 207 766 6900<br />
Apr-07 Expansion F, D, CH Laurent Cadieu +33 1 44 58 92 10<br />
Jul-06 Fund-of-funds EU Olivier Millet +33 1 40 68 17 56<br />
Dec-08 Expansion, buyout F Amar Douhane +33 1 56 37 74 94<br />
Nov-08 Expansion F Den<strong>is</strong> Rodarie +33 4 72 83 23 23<br />
Mar-10 Financial services Global +1 212 813 4900<br />
Jul-07 Buyout, expansion F, EU Patrick L<strong>is</strong>sague +33 1 43 12 01 04<br />
Jul-07 Buyout EU, US Patrick L<strong>is</strong>sague +33 1 43 12 01 04<br />
Jun-09 Buyout, expansion F Aymeric Balmont +33 1 42 56 66 00<br />
Feb-09 Fund-of-funds US, Europe, Asia Hanspeter Bader +41 22 704 41 11<br />
Feb-09 Fund-of-funds Global Hanspeter Bader +41 22 704 41 11<br />
Apr-08 Turnaround F Jean-Lou<strong>is</strong> Detry +33 1 44 20 02 02<br />
Feb-09 Buyout UK, F Nigel Hammond +44 1892 531 373<br />
Apr-10 Venture, growth, cleantech Europe, Israel Joerg Sperling +44 20 7299 41<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 33<br />
www.unquote.com/france
funds-of-funds<br />
unquote<br />
Group Fund name Base Size (m) Closed<br />
Access Capital Partners ACF III Technology F 100 Oct-06<br />
Access Capital Partners Capital Fund IV Growth F 413 May-08<br />
Allianz Private Equity Partners APEP Dachfonds GmbH & Co KG D 750 Mar-06<br />
F&C F&C European Capital Partners LP UK 173 Jul-08<br />
HRJ Capital HRJ Special oppertunities fund I US $195 Apr-08<br />
König & Cie Private Equity Management GmbH König & Cie II International Private Equity D 42 Apr-07<br />
LGT Capital Partner CROWN Premium III LX, D 600 May-07<br />
Lombard Odier Darier Hentsch PE Euro Choice IV CH CHF 776 Jan-09<br />
MPC Münchmeyer Petersen Portfolio Adv<strong>is</strong>ors GmbH Elfte MPC Private Equity GmbH & Co KG D 21.52 Dec-09<br />
Nordcapital Private Equity Nordcapital Private Equity Fonds 8 D 20 Dec-07<br />
Pantheon Ventures Pantheon Europe Fund V UK 1,200 Jun-07<br />
Partners Group Partners Group European Buyout 2005 CH 650 Oct-06<br />
Partners Group Secondary 2008 Partners Group CH 2,500 Dec-09<br />
SGAM AI Private Equity SGAM Private Value Fund F 267 Jul-07<br />
Sw<strong>is</strong>s Re Private Equity Adv<strong>is</strong>ers SRPEP III D 564.3 Mar-06<br />
funds investing<br />
Th<strong>is</strong> table l<strong>is</strong>ts all fully-ra<strong>is</strong>ed funds known <strong>to</strong> be actively seeking investment opportunities in the French market. Information regarding any additional fund<br />
that doesn’t feature on our l<strong>is</strong>t would be well received.<br />
BUYOUT FUNDS<br />
Group Fund name Base Ra<strong>is</strong>ed (m)<br />
21 Centrale Partners 21 Centrale Partners III F/I 330<br />
3i Eurofund V UK 5,000<br />
Abénex Capital AAC France 2005 F 250<br />
Activa Capital Activa Capital II F 320<br />
Advent International Advent International GPE VI UK 6,600<br />
Alchemy Partners Alchemy Investment Plan UK £1,600<br />
Apax Partners SA Apax France VII F 700<br />
Apollo Management Apollo Investment Fund VII US 14,800<br />
Argan Capital Argan Capital Fund UK 425<br />
Argos Soditic Euroknights V F, I,CH 275<br />
ARGUS Capital Ltd ARGUS Capital Partners II UK 262.73<br />
As<strong>to</strong>rg Partners As<strong>to</strong>rg IV F 800.5<br />
AtriA Private Equity AtriA Private Equity III F 300<br />
Aurel NextStage Aurel NextStage FCPR Champion Small Cap I F 100<br />
Avenir Entrepr<strong>is</strong>es Gestion Avenir Entrepr<strong>is</strong>es Développement F 160<br />
Avenir Entrepr<strong>is</strong>es Gestion Avenir Entrepr<strong>is</strong>es Mezzanine F 60<br />
AXA Private Equity AXA Expansion II F 353<br />
AXA Private Equity AXA LBO Fund IV F 1,600<br />
AXA Private Equity AXA Secondary Fund IV F 2,900<br />
Bain Capital Bain Capital IX US $8,000 + $2,000 co-invest<br />
Bain Capital Bain Europe III US 3,500<br />
Balmoral Capital Balmoral I UK n/d<br />
Barclays Private Equity Barclays Private Equity European Fund III UK 2,400<br />
BC Partners BC European Capital VIII UK 5,500<br />
Blacks<strong>to</strong>ne Capital Partners Blacks<strong>to</strong>ne Capital Partners V UK $21,700<br />
Bridgepoint Bridgepoint Development Capital I UK 300<br />
Bridgepoint Bridgepoint European Fund IV UK 5,800<br />
34 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
Type Region Contact Telephone No.<br />
Venture UK, F, D Dominique Peninon +33 1 56 43 61 00<br />
Venture Europe Dominique Peninon +33 1 56 43 61 00<br />
Buyout, venture Global Antje Weykopf +49 89 38 00 17790<br />
Buyout Europe Ham<strong>is</strong>h Mair +44 20 768 8000<br />
D<strong>is</strong>tressed assets Global Duran Cur<strong>is</strong> +1 650 327 50 23<br />
Buyout Europe, US Ralph Günther +49 30 20 30 51 00<br />
Buyout Europe, US Maximilian Brönner +41 55 415 96 00<br />
Fund-of-funds Europe Thomas Frei +41 44 214 1342<br />
Buyout Europe Jens Hochbrunn +49 40 380224128<br />
Fund-of-funds Europe, US Meike Reckling +49 40 37 48 3415<br />
Fund-of-funds Europe Helen Steers +44 20 7484 6200<br />
Buyout - small-mid-large cap Europe Dr Cyrill Wipfli +41 41 768 85 85<br />
Secondary fund positions Europe Dr Cyrill Wipfli +41 41 768 85 85<br />
Fund-of-funds Europe,US Richard Dalaud +33 1 56 37 88 87<br />
Buyout Europe, US Harold We<strong>is</strong>s +41 43 285 21 21<br />
Closed Stage Region<br />
Sep-06 Buyout F<br />
Nov-06 Buyout – mid-market Europe, Asia<br />
Dec-05 Buyout F<br />
Mar-07 Buyout F<br />
Mar-08 Buyout Western Europe/US<br />
n/a Buyout UK, Western Europe<br />
Jun-09 Buyout F<br />
Feb-09 Buyout Global<br />
0ct-06 Buyout Nordic, Western Europe, CEE<br />
May-06 Buyout Europe<br />
Jan-07 Buyout Central & Eastern Europe<br />
May-08 Buyout F<br />
Jan-07 Buyout F<br />
Nov-05 Buyout F, Europe<br />
Mar-08 Buyout, expansion F<br />
Feb-08 Buyout – small-/mid-cap F<br />
Sep-07 Buyout – small-/mid-cap F, D, IT<br />
Jun-08 Buyout F, D, IT<br />
Sep-07 Buyout US, Europe<br />
2006 Buyout Global<br />
2008 Buyout Europe<br />
2007 Buyout UK, Europe<br />
Nov-07 Buyout Europe<br />
May-05 Buyout Europe<br />
Aug-07 Buyout Europe, UK, US<br />
Jul-07 Buyout UK, Europe<br />
Oct-08 Buyout Europe<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 35<br />
www.unquote.com/france
funds investing<br />
unquote<br />
BUYOUT FUNDS<br />
Group Fund name Base Ra<strong>is</strong>ed (m)<br />
Butler Capital Partners France Private Equity III F 325<br />
Candover Candover 2005 Fund UK 3,500<br />
Carlyle Group Carlyle Europe Partners III US 5,350<br />
CCMP Capital Inves<strong>to</strong>rs CCMP II US $3,400<br />
Charterhouse Charterhouse Capital Partners IX UK 4,000<br />
Cinven The Fourth Cinven fund UK 6,500<br />
Climate Change Capital Ltd Climate Change Capital Private Equity fund UK 200<br />
Cobalt Capital Cobalt Investment F 150<br />
Cognetas Cognetas Fund II UK 1,260<br />
CVC Capital Partners CVC European Equity Partners IV UK 6,000<br />
Doughty Hanson Doughty Hanson & Co Fund V UK 3,000<br />
Edmond de Rothschild Capital Partners ERLF II F 300<br />
Electra Partners LLP Electra Partners Club 2007 fund UK £100<br />
Englefield Capital Englefield Capital II UK 1,060<br />
Fidelity Equity Partners FEP 1 UK/US £350<br />
Finadavance Finadvance Capital III F 82<br />
First Reserve Corporation First Reserve Fund XI US $7,800<br />
GI Partners GI Partners Fund III US $1,900<br />
GMT Communications Partners GMT Communications Partners III UK 350<br />
Goldman Sachs GS Capital Partners VI US $20,300<br />
H.I.G. Europe H.I.G. European Partners UK 600<br />
Hellman & Friedman Hellman & Friedman Capital Partners VII US $8,800<br />
HgCapital HgCapital V LP UK £830<br />
IK Investment Partners IK 2007 UK 1,675<br />
Investcorp Technology Partners Investcorp Technology Partners III LP US/UK $500<br />
iXEN Partners iXEN III F 500<br />
Kohlberg Krav<strong>is</strong> Robert KKR European Fund III US 6,000<br />
L Capital Management L Capital FCPR 2 F 325<br />
LBO France Hexagone II F 152<br />
LBO France White Knights VIII F c1,000<br />
MBO Partenaires FCPR MBO II F 150<br />
Montagu Private Equity Montagu III LP UK £2,260<br />
NBGI Private Equity France NBGI Private Equity French Fund I F 100<br />
PAI partners PAI Europe V F 5,400<br />
Palamon Capital Partners Palamon European Equity II LP UK 670<br />
Pamplona Capital Management Pamplona Capital Parnters II LP UK 1,300<br />
Patron Capital Patron Capital LP III UK 895<br />
Pechel Industries Partenaires Pechel Industries III F 165<br />
Permira Permira IV UK 11,000<br />
Pragma Capital Pragma II F 345<br />
Sagard Sagard II F 1,000<br />
Siparex Group Siparex Middle Market II F 150<br />
Summit Partners Summit Partners Europe Private Equity Fund US 1,000<br />
TA Associates TA XI LP US $4000<br />
TCR Capital Partners TCR Capital Partners III F 161<br />
TDR Capital TDR Capital II UK 1,750<br />
Terra Firma Terra Firma Capital Partners III UK 5,400<br />
The Riverside Company Riverside Europe Fund III BE 315<br />
TowerBrook Capital Partners LP TowerBrook Inves<strong>to</strong>rs II LP UK 1,300<br />
Vespa Capital Vespa Capital UK 80<br />
Vitruvian Partners Vitruvian Partners I UK 925<br />
Warburg Pincus Warburg Pincus Private Equity X LP US $15,000<br />
Weinberg Capital Partners WCP I F 4<br />
36 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
Closed Stage Region<br />
Sep-05 Buyout F<br />
Nov-05 Buyout Europe, US<br />
Sep-07 Buyout US, Europe<br />
Jan-08 Buyout, expansion US, Europe, Asia<br />
Arpil-09 Buyout Europe, UK<br />
Jun-06 Buyout Europe, UK<br />
Sep-07 Buyout, expansion – cleantech Europe<br />
Jan-07 Buyout Europe<br />
Jul-05 Buyout Western Europe<br />
Aug-05 Buyout Europe<br />
May-07 Buyout Europe<br />
Feb-08 Buyout F<br />
Jun-08 Buyouts, expansion, mezzanine UK, Europe<br />
Jan-07 Buyout UK, Europe<br />
Apr-07 Buyout UK, Europe<br />
Jun-06 Buyout F<br />
Jul-06 Buyout, expansion – energy US, UK, Europe<br />
Nov-08 Buyout US, UK, Europe<br />
Jul-07 Buyout UK, Europe<br />
Jun-07 Buyout Global<br />
Jul-07 Buyout UK, Europe<br />
Nov-08 Buyout US, UK, Europe<br />
Feb-06 Buyout Europe, UK<br />
Oct-07 Buyout Europe<br />
Jan-08 Buyout – technology US, Europe<br />
Nov-08 Buyout F<br />
May-08 Buyout Europe<br />
Mar-06 Buyout Europe, US<br />
Jul-06 Buyout Europe<br />
Mar-09 Buyout Western Europe<br />
Jun-06 Buyout F<br />
Jun-05 Buyout Europe, UK<br />
Jan-09 Buyout, expansion F<br />
May-08 Buyout Europe<br />
Jun-06 Buyout, expansion Europe<br />
Sep-07 Bu<strong>to</strong>ut, expansion Europe, North America<br />
Mar-07 Buyout, expansion Europe<br />
Oct-08 Buyout, expansion F<br />
Sep-06 Buyout Europe, US, Japan<br />
Apr-08 Buyout F<br />
Dec-06 Buyout F<br />
May-08 Buyout – small-mid-cap F<br />
May-08 Buyout Europe<br />
Sep-09 Buyout, expansion US, Europe, India<br />
May-08 Buyout F<br />
Jun-06 Buyout – mid-market Western Europe<br />
May-07 Buyout UK, Europe<br />
Jul-07 Buyout UK, Europe<br />
Mar-06 Buyout – mid-market US, UK, Europe<br />
Mar-10 Buyout F, UK<br />
Feb-08 Buyout UK, Northern Europe<br />
May-08 Buyout Global<br />
Jan-06 Buyout F, Southern Europe<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 37<br />
www.unquote.com/france
funds investing<br />
unquote<br />
EARLY-STAGE/EXPANSION FUNDS<br />
Fund name Group Base Ra<strong>is</strong>ed (m)<br />
360º Capital Partners 360º Capital Partners F/I 100<br />
3i Growth Capital fund UK 1,200<br />
Accel Partners Accel London III UK $525<br />
Access Capital Partners ACF III Technology F 307<br />
Advent Venture Partners Advent Private Equity Fund IV UK £129<br />
Alven Capital Alven Capital III F 100<br />
Amadeus Capital Partners Amadeus III UK £160<br />
Atlas Venture Atlas Venture Fund VIII UK $283<br />
Balder<strong>to</strong>n Capital Benchmark Europe III UK $550<br />
Bellevue Group BB Biotechventures CH 104<br />
Capricorn Venture Partners Capricorn Cleantech Fund BE 100<br />
Credit Agricole Private Equity Capenergie F 109<br />
Demeter Partners 2 Demeter 2 F 203<br />
DFJ Esprit Prelude Trust Plc UK £50<br />
Earlybird Earlybird IV D 127<br />
Edmond de Rothschild Investment Partners Winch Capital 2 F 250<br />
Emerald Technology Ventures SAM Private Equity Sustainability Fund II CH 135<br />
Emertec Gestion Emertec IV F 60<br />
Environmental Technologies Fund Environmental Technologies Fund UK 100<br />
Epi-V Epi-V UK 50<br />
Frontiers Capital Frontiers Capital III UK £25<br />
Hasso Plattner Ventures Hasso Plattner Ventures Europe UK 100<br />
Index Ventures Index Ventures Growth I LP UK 400<br />
Index Ventures Index Ventures V CH 350<br />
Innovacom Innovacom 6 F 150<br />
I-Source Gestion I-Source 3 F 60<br />
Kennet Partners Kennet III UK 200<br />
Lime Rock Partners Lime Rock Fund V US $1,400<br />
Milk Capital Milk Capital F 20<br />
NanoDimension AG NanoDimension LP Cayman Islands 45<br />
NBGI Ventures NBGI Technology Fund II UK 30<br />
NeoMed NeoMed Innovation IV N 104<br />
Newfund Newfund 1 F 72<br />
Partech International Partech Funds V US/F $250<br />
Perusa Partners Perusa Partners I UK 155<br />
Platina Finance Ltd European Renewable Energy Fund 1 LP UK £75<br />
Serena Capital Serena Capital F 100<br />
Sofinnova Parnters Sofinnova Capital VI F 260<br />
SV Life Sciences SV Life Sciences Fund IV US $572<br />
Ventech Ventech Capital III F 150<br />
Welling<strong>to</strong>n Partners Welling<strong>to</strong>n Partners Ventures IV Technology UK 265<br />
XAnge Xpansion F 50<br />
OTHER FUNDS<br />
Fund name Group Base Ra<strong>is</strong>ed (m)<br />
Ac<strong>to</strong> Mezzanine Ac<strong>to</strong> Mezzanine F 187<br />
Babson Capital Europe Almack Mezzanine I UK 800<br />
CIC Mezzanine CIC Mezzanine II F 107<br />
ARCIS Group ESD Fund IV UK 354<br />
Intermediate Capital Group Plc European Mezzanine Fund IV UK £1,250<br />
IFE Conseil IFE Conseil II LX 300<br />
Indigo Capital Indigo Capital V UK 550<br />
Kreos Capital Kreos III UK 200<br />
Park Square Capital Park Square Capital Partners LP UK 1,050<br />
Partners Group Partners Group Global Mezzanine 2007 CH 447<br />
Summit Partners Summit Partners Subordinated Debt Fund IV US $825<br />
38 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
Closed Stage Region<br />
Apr-08 Early-stage F, I<br />
Mar-10 Expansion UK, Europe<br />
Dec-08 Early-stage, expansion Europe, Israel<br />
Oct-06 Early-stage UK, Europe<br />
Dec-05 Early-stage Europe, US<br />
Mar-08 Early-stage, expansion F<br />
Mar-07 Early-stage UK, Europe<br />
Feb-09 Early-stage Europe, US<br />
Nov-06 Early-stage UK, Europe<br />
Jan-06 Early-stage Europe, US<br />
Jun-08 Early-stage Europe<br />
Sep-07 Early-stage, buyout F, UK, I, D<br />
Dec-09 Early-stage, expansion F,D, ES<br />
Apr-00 Early-stage UK, Europe<br />
Sep-08 Early-stage, expansion Western Europe<br />
Nov-09 Expansion F<br />
Apr-07 Early-stage – cleantech US, UK, Western Europe<br />
Jan-09 Early-stage F<br />
Oct-07 Early-stage – cleantech UK, Europe<br />
Aug-07 Early-stage – energy UK, Europe, US<br />
Jun-06 Early-stage UK, Europe<br />
Jul-08 Early-stage Europe, Isreal<br />
Jan-08 Expansion Europe<br />
Mar-09 Early-stage UK, Europe, Israel<br />
Nov-07 Early-stage, expansion F, Europe, US<br />
Mar-08 Early-stage, expansion Western Europe<br />
Jul-08 Expansion, technology US, Europe<br />
Jun-08 Expansion – energy US, UK, Europe<br />
Jul-08 Early-stage, expansion Global<br />
Mar-07 Early-stage – nanotechnology Europe, North America<br />
Aug-07 Early-stage – medical technology Europe/US<br />
Jan-06 Early-stage N, SWE, F, CH<br />
Jul-09 Early-stage, Expansion F<br />
Jun-08 Early-stage, expansion US, Europe<br />
Apr-08 Early-stage DACH, Europe<br />
Jan-08 Early-stage, expansion – renewable energy Europe<br />
Jul-09 Early-stage, expansion F, Western Europe<br />
Feb-10 Early-stage, expansion Europe<br />
Feb-07 Early-stage – life sciences US, UK, Europe<br />
Nov-07 Early-stage Europe<br />
Jan-08 Early-stage, expansion Europe<br />
Apr-08 Expansion F<br />
Closed Stage Region<br />
Mar-08 Mezzanine F<br />
Jun-06 Mezzanine UK, Europe<br />
May-09 Mezzanine France<br />
Oct-08 Secondaries Europe<br />
Apr-07 Mezzanine UK, Europe<br />
Nov-06 Mezzanine BE, NL, LX, D, F, ES, I<br />
Jul-07 Mezzanine Europe<br />
Apr-07 Venture debt UK, Europe, Israel<br />
Jan-05 Mezzanine UK, Europe<br />
May-08 Mezzanine Europe<br />
May-08 Mezzanine US, EU<br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 39<br />
www.unquote.com/france
IPO tracker<br />
unquote<br />
The table below tracks the performance of previously private equity-backed French companies as l<strong>is</strong>ted s<strong>to</strong>ck<br />
Company ICB Subsec<strong>to</strong>r Name Original deal Equity Syndicate<br />
Buyouts<br />
Bureau Veritas Business Support Services n/d, 1995 Wendel Invest<strong>is</strong>sement<br />
Fountaine Pajot Commercial Vehicles & Trucks n/d, 2002 21 Centrale Partners<br />
Homair Hotels n/d, 2005 Montefiore Investment, Avenir Tour<strong>is</strong>me, Uni<br />
Expansion Ouest, Grand Sud Ouest Capital<br />
Legrand Electrical Components & Equipment 3.7bn, 2002 Wendel Invest<strong>is</strong>sement, KKR<br />
Médica Healthcare Equipment & Services 750m, 2006 BC Partners, AXA Private Equity<br />
Outremer Telecom Mobile Telecommunications 70m, 2004 Apax Partners<br />
Rexel Electrical Components & Equipment 3.8bn , 2005 Clay<strong>to</strong>n Dublier & Rice, Eurazeo, Merrill Lunch<br />
Global Private Equity<br />
Seloger.com Real Estate Holding & Development 50m, 2000 AXA Private Equity, Galileo Partners, Alpha<br />
Associes, Alven, Europ@web<br />
Arkoon Software 3.6m, 2003 Sigefi Private Equity, ACE Management, CDC<br />
Entrepr<strong>is</strong>es, Siparex, Initiative & Finance<br />
Au<strong>to</strong> Escape Specialized Consumer Services n/d, 2005 Ofi Private Equity, Viver<strong>is</strong> Management<br />
Carmat Health Care Equipment & Services 7.25m, 2008 Truffle Venture<br />
Celect<strong>is</strong> Biotechnology 13.6m, 2002 BioMedical Venture, AGF Private Equity, Edmond<br />
de Rothschild Investment Parnters, KamInvest,<br />
Odysee Venture<br />
Eurogerm Food Products 5.8m, 2004 Siparex, Carvest<br />
Europacorp Broadcasting & Entertainment n/d GCE JIC<br />
Venture<br />
Innate Pharma Biotechnology 5m, 1999 Sofinnova Partners, GIMV, Auriga Partners, Alta<br />
Partners, AXA Private Equity, Gilde Pechel, Innover<strong>is</strong><br />
LeGuide.com Media Agencies n/d, 2000 Sigefi Ventures Gestion<br />
Metabolic Explorer Speciality Chemicals Ffr 10m, 2000 Spef Ventures, Sofimac, Credit Lyonna<strong>is</strong> Private<br />
Equity, Viver<strong>is</strong> Management, Credit Agricole<br />
Private Equity, SGAM AI<br />
Parrot Telecommunications Equipment 0.55m, 2005 Sofinnova Partners, EPF Partners, Spef Ventures,<br />
SGAM, CIC<br />
Vergnet Industrial Machinery 75k, 1993 Centre Capital Developpement, Demeter Partners,<br />
IPO, CM-COC Capital Prive, Centre Loire Expansion,<br />
Sofimac Partners<br />
Ve<strong>to</strong>quinol Biotechnology 40m, 2003 Banexi Capital Partenaires, 3i<br />
Vival<strong>is</strong> Biotechnology 3m, 2003 FCJE, Creagro, Pays de la Loire Developpement,<br />
Sodero, Dahlia<br />
* country specific sec<strong>to</strong>r index.<br />
Source: Bloomberg<br />
40 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
unquote<br />
IPO date<br />
Prime<br />
Exchange<br />
Issue price<br />
Market cap<br />
at IPO<br />
P/E Ratio<br />
Industry<br />
benchmark P/E<br />
ratio*<br />
Share price<br />
14/07/2010<br />
Price change<br />
since IPO<br />
Oct-07 Euronext Par<strong>is</strong> 37.75 4.38bn 19.27 n/a 48.60 29% <br />
Jun-07 Euronext Par<strong>is</strong> 30 46m n/a 19.29 10.35 -66% <br />
Jun-07 Euronext Par<strong>is</strong> 5.1 65m 19.66 n/a 2.96 -42% <br />
Apr-06 Euronext Par<strong>is</strong> 19.75 5.35bn 21.62 13.11 25.15 27% <br />
Feb-10 Euronext Par<strong>is</strong> 13 623m n/a 15.1 14.27 10% <br />
Apr-07 Euronext Par<strong>is</strong> 17 360m n/a 16.36 4.30 -75% <br />
Apr-07 Euronext Par<strong>is</strong> 16.5 4.22bn 29.04 13.11 12.19 -26% —<br />
Jan-07 Euronext Par<strong>is</strong> 22.5 375m 27.14 n/a 30.10 34% —<br />
3-month<br />
trend<br />
Jul-07 Euronext Par<strong>is</strong> 4.61 21m n/a n/a 1.37 -70% —<br />
Mar-07 Euronext Par<strong>is</strong> 5.53 29m n/a n/a 2.40 -57% <br />
Jun-10 Euronext Par<strong>is</strong> 18.75 75m n/a n/a 22.15 18% —<br />
Feb-07 Euronext Par<strong>is</strong> 10.25 94m n/a 13.98 8.40 -18% <br />
Apr-07 Euronext Par<strong>is</strong> 16.73 72m 16.4 n/a 9.93 -41% <br />
Jun-07 Euronext Par<strong>is</strong> 15.5 315m 11.26 n/a 5.01 -68% <br />
Dec-06 Euronext Par<strong>is</strong> 4.5 112m n/a 13.98 1.80 -60% <br />
Aug-06 Euronext Par<strong>is</strong> 9.2 31m 22.33 n/a 23.00 150% <br />
May-07 Euronext Par<strong>is</strong> 8.4 170m n/a n/a 5.43 -35% <br />
Jul-06 Euronext Par<strong>is</strong> 23.5 306m 18.32 16.36 12.25 -48% <br />
Aug-07 Euronext Par<strong>is</strong> 13.85 86m n/a 19.29 4.44 -68% <br />
Jan-07 Euronext Par<strong>is</strong> 21 237m 15.1 n/a 24.47 17% —<br />
Jun-07 Euronext Par<strong>is</strong> 10.51 151m n/a n/a 6.94 -34% <br />
ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 41<br />
www.unquote.com/france
diary dates<br />
unquote<br />
15-17 September 2010<br />
Capital Creation 2010<br />
Le Meridien Beach Plaza, Monte Carlo<br />
www.capitalcreationeurope.com<br />
12-13 Oc<strong>to</strong>ber 2010<br />
EVCA Buyout Forum<br />
Copenhagen, Denmark<br />
www.evca.eu/buyoutforum2010/home.html<br />
13 Oc<strong>to</strong>ber 2010<br />
The AFME/EHYA 5th Annual EHYA Leveraged Finance Conference<br />
The Lancaster London Hotel<br />
Lancaster Terrace<br />
London, W2<br />
Tel: +44 20 7262 6737<br />
www.lancasterlondon.com<br />
14 Oc<strong>to</strong>ber 2010<br />
unquote” Deutsche Private Equity Congress<br />
Munich, Germany<br />
Tel: +44 20 7484 9884<br />
Email: nicola.tillin@inc<strong>is</strong>ivemedia.com<br />
www.deutschepecongress.com<br />
14-15 Oc<strong>to</strong>ber 2010<br />
EVCA Venture Capital Forum<br />
Copenhagen, Denmark<br />
www.evca.eu/venturecapitalforum2010/home.html<br />
4 November 2010<br />
The unquote” Brit<strong>is</strong>h Private Equity Awards 2010<br />
The Northumberland<br />
London, UK<br />
Tel: +44 20 7004 7453<br />
Email: helen.longhurst@inc<strong>is</strong>ivemedia.com<br />
www.brit<strong>is</strong>hprivateequityawards.com<br />
11 November 2010<br />
unquote” Italia Private Equity Congress<br />
Milan, Italy<br />
Tel: +44 20 7484 9884<br />
Email: nicola.tillin@inc<strong>is</strong>ivemedia.com<br />
www.italiapecongress.com<br />
16-19 November 2010<br />
SuperInves<strong>to</strong>r 2010<br />
Westin Hotel<br />
Par<strong>is</strong>, France<br />
www.icbi-events.com/superinves<strong>to</strong>r<br />
10 December 2010<br />
The PE Inves<strong>to</strong>r Relations Conference<br />
London, UK<br />
www.bieevents.com/peir-details<br />
42 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />
www.unquote.com/france
Subscription Packages and Reports<br />
The following subscription packages and reports are available from unquote”.<br />
Regional subscription packages<br />
Choose one or more of the following regions:<br />
And choose your subscription package:<br />
Standard Standard Plus Corporate Enterpr<strong>is</strong>e<br />
Deals, Funds and Exits <br />
Monthly Regional Round Up (pdf) <br />
Monthly European Overview (in print) <br />
Special<strong>is</strong>t Intelligence Reports <br />
Email News Bulletins <br />
Archives <br />
Regions 1 1 2 or more All<br />
Multiple Sites 2 Unlimited<br />
Multiple Users 10 Unlimited<br />
Annual Reports Buyout Review Buyout Review All<br />
Who’s Who in Private Equity Online <br />
From £1,200 From £1,500 From £2,000 POA<br />
Annual Reports & Who’s Who<br />
most<br />
popular<br />
Our two annual reports and our online direc<strong>to</strong>ry Who’s Who in Private Equity are also available <strong>to</strong> buy separately:<br />
Who’s Who in Private Equity<br />
www.whoswhoinprivateequity.com<br />
Th<strong>is</strong> online direc<strong>to</strong>ry contains<br />
profiles of more than 4,000 key<br />
contacts from approximately<br />
1,500 companies in 15 European<br />
countries, including legal and<br />
corporate finance adv<strong>is</strong>ers.<br />
From £695<br />
European Buyout Review<br />
www.europeanbuyoutreview.com<br />
Th<strong>is</strong> annual reference guide<br />
contains buyout stat<strong>is</strong>tics and<br />
analys<strong>is</strong> of the market in each major<br />
European country. Includes l<strong>is</strong>ts of<br />
equity and mezzanine providers and<br />
major deals completed.<br />
£1,195<br />
European Fundra<strong>is</strong>ing Review<br />
www.unquote.com/research<br />
The annual source for fundra<strong>is</strong>ing in<br />
Europe. Analyses trends in capital<br />
ra<strong>is</strong>ed and sought, fund sizes and<br />
fundra<strong>is</strong>ing cycles.<br />
£995<br />
unquote.com<br />
For more information or <strong>to</strong> order any of the products l<strong>is</strong>ted, please contact<br />
Nicola Tillin on +44 (0)20 7484 9884 or nicola.tillin@inc<strong>is</strong>ivemedia.com
Private Equity Market Intelligence<br />
As easy as<br />
1,2,3<br />
Deals Intelligence<br />
Global Portfolio Company Performance Data<br />
Fundra<strong>is</strong>ing & LP Information<br />
PRIVATE EQUITY INSIGHT EXCLUSIVE FREE TRIAL OFFER<br />
GLOBAL PORTFOLIO COMPANY PERFORMANCE DATA FREE TRIAL OFFER<br />
Private Equity Insight’s unique Performance Analyser provides the only way <strong>to</strong>: Compare forecast performance models with aggregated actual data;<br />
track performance of portfolio investments; identify performance excellence; track and analyse trends; and ultimately ensure<br />
optimum returns. So, you can either keep making dec<strong>is</strong>ions in the dark, or you can begin <strong>to</strong> base every dec<strong>is</strong>ion on fact.<br />
For more information or <strong>to</strong> arrange your no obligation FREE TRIAL v<strong>is</strong>it www.privateequityinsight.com or email nicola.tillin@inc<strong>is</strong>ivemedia.com<br />
Private Equity Insight - It’s as easy as 1, 2, 3.<br />
unquote